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Abstract
Structural Studies of Peptide Toxins and their Binding Properties Towards the
Voltage Sensing Domain of Nav1.7
By
Ryan Schroder

Advisor: Sebastien Poget

Voltage gated sodium channels (VGSCs) are essential to the propagation of nerve cell
impulses and thus communication in the nervous system. VGSCs are comprised of four
repeating units of six transmembrane helices. Of the six transmembrane helices, the first four
(called S1-S4) comprise the voltage sensing domain (VSD) and the last two (S5-S6) comprise the
pore domain (PD)1. The Human voltage-gated sodium channel NaV1.7 has been shown to play a
vital role in the nerve pathways that induce pain response2. Many of the currently available pain
therapeutic drugs are opiates, derivative molecules of opium. These drugs target receptors in
the brain that result in many other effects in addition to pain relief, such as euphoria, which
gives such drugs a high risk for misuse. Drugs that target and inhibit NaV1.7 on the other hand
should only affect the pain signal and therefore lead to less addiction problems than opiatebased medications. Animal peptide toxins with high specificity towards NaV1.7 can potentially
serve as lead compounds for the design of such drugs. One example of such a toxin is the
tarantula toxin Protoxin II (ProTxII). Although the cryo-EM structures of hNav 1.7 in complex
with ProTxII have been reported, the resolution of the toxin-channel binding interface is poor3
4

. Therefore, obtaining a deeper understanding of the toxin-channel binding interface is still a

crucial pursuit for the advancement of rational drug design in targeting NaV1.7 for potential pain
iv

relief. GpTxI is another tarantula toxin that has been shown to selectively bind to Nav 1.75.
GpTxI is of particular interest because the toxin itself has been shown to exhibit analgesic
effects6. Therefore, it would be beneficial to obtain structural information on GpTxI-NaV1.7
interactions to help detect determinants of their relative specificity and binding affinity for the
channel. In this study, we expressed, purified and refolded the voltage sensing domain (VSD) of
repeat II of this channel with the aim of conducting ligand binding and structural studies via
solution state NMR spectroscopy. We have successfully expressed the recombinant voltage
sensing domain (VSD) by using the Trp-Delta-Ldr inclusion body system7. The fusion protein
was cleaved with hydroxylamine using an added NG sequence between the fusion partners. The
VSD was then refolded using the zwitterionic lipid, DMPC. Micro-scale thermophoresis (MST)
was used to confirm binding of the recombinant VSD to Protoxin-II. Additionally, GpTxI was
synthesized and refolded for binding and NMR studies with Nav 1.7 VSD-II. In this study, we
show that Nav 1.7 VSD adopts a native-like conformation due the high-affinity binding between
the VSD and ProTxII and GpTxI. Moreover, we have produced the mutations F813A and
D816A in the S3/S4 linker region of the VSD and found the binding affinity towards GpTxI is
significantly decreased. Thus, we have found residues of the VSD which are likely to be directly
involved with the binding of Nav 1.7 and the analgesic toxin, GpTxI. In addition, we have
perofmed HSQC NMR experiments on the Nav 1.7 VSD in lyso-myristoyl phosphocholine
(LMPC) micelles in aim to optimize NMR conditions for further investigation using 3dimensional NMR experiments. In addition, we have solved the solution-state NMR structure of
a novel Terebrid toxin from Terebra subulata. The novel toxin, known as Tsu1.1, has the
potential to target receptors that are involved with appetite signaling, as it has been found to
significantly affect the apetite of Drosophila8. Also, being that this toxin has not been extensively

v

investigated for targets, there could be numerous potential rational drug design applications in
the structural findings of Tsu1.1.
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Introduction:
Voltage gated sodium channels (VGSCs) are a type of ion channel that are crucial for
excitatory cell communication. Excitatory cells include muscle cells and neurons in animals. For
example, when a neuron receives excitatory neurotransmitters from neighboring cells, this
results in the opening of ligand gated sodium channels which cause sodium influx into the cell
cytosol. This event results in a net positive charge in the cytosol, leading to conformational
changes in the voltage sensing region of the voltage gated sodium channels. The positive charge
is “sensed” by repeating units of positively charged residues such as arginine located on the
transmembrane helices of the voltage sensing domain (VSD)9. The general architecture of
VGSCs is highly conserved, as can be seen from primary sequence analysis of these channels
across different species1. These ion channels are comprised of four voltage sensing domains and
a pore domain. VGSCs have four domains and each of those domains contains six
transmembrane helices. In bacterial VGSCs, these domains are in general the same. In higher
animals such as mammals, the four domains of VGSCs have different sequence, yet their general
architecture is quite similar. The figure below illustrates the general layout of VGSCs. The
peptide chains labeled β1 and β2 constitute the β-subunit, which is not part of the functional
ion channel, but play a role in modulation of function of VGSCs in mammals1. The α-subunit is
the portion of the protein that is comprised of the four domains which constitute the ion
channel. The VSD is comprised of four transmembrane helices, known as S1, S2, S3 and S4.
The S4 helix specifically has positively charged residues, usually arginine in a repeating
arrangement such that there is one arginine at every third position, with hydrophobic residues
occupying the positions in between. The conformational switch that results in channel activation
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Figure 1: Schematic layout of a eukaryotic VGSC. Repeating units of the pseudo-heterotetramer are labeled with
roman numbers I-IV11

is initially due to the motion of S4 outwardly away from the inside of the cell due to
electrostatic interactions9. This conformational switch leads to the opening of the pore region
of the channel to be able to conduct sodium ions. The pore region is formed by the fifth and
sixth transmembrane helices from each domain, which are known as S5 and S6. At the peak of
the action potential, a part of the intracellular region with three conserved residues, called the
inactivation gate undergoes a conformational change in such a way that the pore is blocked and
no longer able to conduct sodium ions. This process is known as fast inactivation and is
necessary for the excitable cells to repolarize after a depolarizing action potential. The three
conserved residues are isoleucine, phenylalanine, methionine (IFM)1. There are some general
features of VGSCs that are essentially the same across multitudes of species. However, many
isoforms of VGSCs are known and one of their distinguishing factors are different specificities
2

of binding partners (such as inhibitors). For example, the tarantula derived peptide toxin
ProTx-II has specificity towards the VSD of the Human VGSC Nav 1.7 VSD-repeat II12. This has
been shown originally by point mutation and functional studies such as electrophysiology. This
toxin belongs to the gating-modifier toxins that are thought to inhibit the channel by preventing
the conformational switch that the S4 helix undergoes upon depolarization of the host cells
transmembrane potential13.
There exists a wide variety of peptide toxins that are produced by venomous animals
that have evolved to target VGSCs of their prey. There are many different types of these toxins
found in nature that have evolved to bind to the extracellular loop which connects the S3 and
S4 helices of VGSCs. One class of peptide toxins that are found in scorpion venom are the
αscorpion toxins, which bind to this region and inhibit the channel14. Other peptide toxins from
sea anemone venom have been shown to have the same effect and bind to this S3-S4
extracellular loop of VGSCs as well15. Since this region of the channel is critical for controlling
the gating properties, it makes sense that peptide toxins from a variety of species have evolved
to target their prey by binding to this region and modifying the gating properties. This region is
referred to as the paddle motif, being that it is comprised of an extracellular loop that
somewhat resembles a paddle. There are also many types of toxins that inhibit VGSCs by
blocking the pore from being able to conduct sodium ions directly, which are called pore
blockers. Pore blockers include the pufferfish heterocyclic tetrodotoxin and peptide 𝜇
conotoxins, which are found in the venom of cone snails14. The study of such gating modifier
toxins and their interactions with VGSCs has applications in the field of rational drug design.
The human voltage-gated sodium channel Nav 1.7 has been implicated in neuronal pain
response2. The VGSC Nav 1.7 is one of the 9 major isoforms of Human VGSCs1. VGSCs are
3

responsible for the excitation of the neurons that they are expressed on, via inducing Action
Potential1. Nav 1.7 has been shown to be preferentially expressed on neurons that are involved
with pain response signals2. It has also been shown that mice that lack this channel are not
responsive to pain. The current standard for pain relief medications involves opiates, derivative
molecules of opium. Such drugs target receptors in the brain and result in pleasure sensation
from the indirect release of dopamine16. This characteristic gives such drugs a high risk for
misuse. Therefore, drugs that can target and inhibit pain response through an alternative route
could have great potential in the market of pain medications since it would likely not pose the
problem of addiction that opiate based medications do. Because it has been established that
the channel Nav 1.7 is expressed on pain reception neurons, this makes it an excellent candidate
for pain relief targeting. The inhibition of this channel’s activity would likely result in the
absence of pain response. In addition, it has been shown that treatment of mice with a gatingmodifier toxin inhibitor of Nav 1.7 called GpTxI had similar pain-relieving effect than that of
morphine and did not produce any clear adverse effects6. Therefore, this channel provides an
alternative target for potential pain therapeutic drugs. The opiate based medications are not
only harmful to the liver, but they pose the risks of severe addiction. Therefore, it is of great
interest to develop pain relief drugs that can target alternative pathways that do not pose such
risks.
There is a growing interest in the development of drugs that can be used as pain
therapeutics that are not derivatives of opium. Rational drug design is arguably the future
cornerstone of pharmacological research. For one to embark on the design of a novel drug
using the rational approach, the structure of the protein being targeted must be known,
preferably at atomic resolution. This may be the rate limiting step in the rational drug design of
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many potential therapeutics. Many protein targets of drugs are membrane proteins to which
the drug can bind and either enhance or decrease the functional activity of the protein.
Structural determination of membrane proteins is among the most challenging tasks in
biophysics today. The development of new methods and the possible improvement of existing
methods used to achieve such tasks have impact on the field of membrane protein structural
biology. In addition to rational drug design application, structural determination of membrane
proteins such as VGSCs will provide insights into the details of their function at the atomic
level. Such findings can potentially lead to advancements in other fields of science such as
physiology and neuroscience.
The crystal structure of a Nav 1.7 VSD (repeat II)/Nav Ab chimera in complex with
ProTxII was reported with a resolution of ~3.5 Angstroms at the toxin/VSD binding interface4.
In addition, the cryo-electron microscopy structure of full-length Nav 1.7 in complex with
ProTxII has been reported, with a resolution of ~5 Angstroms at the toxin binding interface3.
Although these are both significant strides in the field of Nav 1.7 research, the resolution of the
binding interface would need to be improved before a rational drug design project could be
attempted. An alternative approach is to use solution-state NMR to determine the structure of
an isolated Nav 1.7 VSD in complex with a gating-modifier toxin in aqueous solution or solidstate NMR of the protein complex embedded in a phospholipid bilayer. Having a molecularresolution structure of the binding interface between the VSD of Nav 1.7 in complex with a
gating-modifier toxin determination of this channel would be helpful for being able to
understand what type of molecules could interact with and potentially inhibit the channel. Such
molecules could potentially be drugs that will effectively block pain. Additionally, NMR could be
used to determine information regarding the dynamics of toxin-binding with Nav 1.7 10.
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One type of solution-state NMR experiment that can be used to determine which
residues are involved with binding in a VSD-toxin complex is a Heteronuclear Single Quantum
Coherence (HSQC) experiment. The HSQC experiment results in a 2-dimensional NMR
spectrum which consists of 1H chemical shifts on one axis and 15N chemical shifts on the other.
The peaks in the spectrum represent pairs of 1H/15N which are directly bonded to one
another17. This type of experiment can directly be used to determine information regarding
which residues of the VSD are involved with toxin-binding. The former can be achieved if the
experiment is performed in the following manner. The recombinant Nav 1.7 VSD would be
labeled with 15N, while the toxin of interest such as ProTxII is not be labeled. The HQSC
experiment would be performed on the VSD without the toxin present, followed by the serial
addition of toxin in an experiment known as HSQC titration. In a HSQC titration, one can
determine residues that are likely to be directly involved with binding, as corresponding peaks
in the spectrum will shift systematically, in correspondence with the addition of toxin. This is to
say, a peak that shifts in one direction upon addition of toxin, should continue to shift in the
same direction until saturation is reached. The effect of binding on chemical shifts is known as
chemical shift perturbation18. Peaks that undergo chemical shift perturbations in a HSQC
titration experiment correspond to residues which are likely to be directly involved with
binding.

In some cases, it is useful to study a bacterial voltage gated ion channel as a model for a
mammalian channel analog. Such cases include studying binding interactions of inhibitor
molecules with the bacterial channel and subsequent mechanisms and dynamics of gating
modification (i.e. conformational changes). If one is interested in determining information
6

regarding the structural and dynamical nature of toxin-binding to the human Nav 1.7 by NMR for
instance, it would be of great benefit to understand molecular details of these processes in a
simpler system, such as a bacterial VGSC. This is because full human channel conformational
states/transitions would be difficult or impossible to study by NMR or with molecular dynamics
and these processes can be modeled using information obtained from a simpler system which
would be more feasible to study using these techniques. Since the full-length human VGSCs
such as Nav 1.7 are too large to be studied by NMR, the former approach could be ideal.
Nav 1.7 is a 1977-amino acid protein, which makes solution NMR studies of the intact channel

impossible. This is largely due to the fast relaxation rates experienced in such a large complex,
in addition to severe NMR peak overlap in a protein as large as this. Bacterial VGSCs are
generally much smaller (200-250 amino acids per chain) and they are homotetrameric as
opposed to the pseudotetrameric mammalian sodium channels. Therefore, it would be useful to
find a model bacterial VGSC analog for Nav 1.7 to study the full channel effect of toxins binding.
It has been shown that Nav Rh is a superior model for mammalian VGSCs compared with
other bacterial VGSCs due to the mechanism by which sodium ions permeate through the
selectivity filter1. In mammalian channels, the sodium ion selectivity filter consists of an
asymmetric pore, while in most bacterial VGSCs, the pore is symmetric. However, in Nav Rh
the pore region is asymmetric, as it is in mammalian channels19. Therefore, the mechanism of
ion conduction in Nav Rh likely has more similarities to mammalian VGSCs than other known
bacterial channels. This lends to the possibility of analogous gating modification mechanisms
between Nav Rh and mammalian VGSCs such as Nav 1.7. Nav Rh is a homotetrameric VGSC,
for which the crystal structure of the closed-pore state has been reported19. In the closed state,
the channel does not conduct sodium ions. The structure of the open-pore state conformation
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of this channel is currently unknown. There are specific types of molecular dynamics (MD)
simulations that are available which can allow one to obtain a possible trajectory of a
conformational switch by minimizing the RMSD between the Cα peptide backbone atoms
between two different structures by calculating the optimal (lowest energy) rotation that
achieves such minimization20. These simulations are useful when the structure of a protein has
been solved in one conformational state and the same protein or another structurally
homologous protein has a reported structure in a distinctively different conformation. In this
case, one could use the RMSD minimizing simulation, known as RMSD colvars (colvars as short
for collective variables) to calculate the optimum rotation matrix that will project the set of
user defined coordinates in one structure file to another set of reference coordinates in
another structure file. Then, an external force can be applied directly to the RMSD colvars to
push the atomic coordinates of the protein of interest to that of the reference protein. This is
one method that one could use to determine the dynamical trajectory of a conformational
switch in an MD simulation. This trajectory can then be analyzed with free energy calculation
MD simulation techniques such as Adaptive Biasing Force (ABF), which will calculate the free
energy of the conformational switch21. The former MD simulations could be used in the case of
the Nav Rh structure in the closed-pore state, while using reference coordinates from a
homologous channel which has been reported in the open-pore state. This is an example of
one way in which one can use MD simulations to study conformational transitions of proteins,
an area of vast inquiry.
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Toxins and Voltage Gated Sodium Channels:

Introduction:
Voltage gated sodium channels (VGSCs) are membrane proteins that are crucially
involved with the initiation and propagation of action potential in excitatory cells22. VGSCs are
comprised of two functional domains: the voltage sensing domain (VSD) and the pore domain
(PD). The VSDs are comprised of the S1-S4 transmembrane helices of each of the
(pseudo)tetrameric channel’s four repeating units. The S5-S6 helices from all four repeating
units together form a single PD23. In eukaryotes, these channels are pseudo-heterotetrametric
and each of the four repeats contributes one unique VSD and all together form the single PD.
Within the VSD, the S4 helix comprises the actual voltage sensor of the VGSC. The S4 helices
are rich in positively charged residues and they cause the helix to change conformation upon
depolarization of the resting cell transmembrane potential23.

There are ten known isoforms of human VGSCs. Nav 1.7 is an isoform of therapeutic
interest since it has been shown to be involved with pain response2. Molecules that could bind
to and inhibit this channel could potentially be used as pain therapeutics that might not pose the
dangers that are associated with opiate based medications. Toxins offer great insight into the
binding profiles of VGSCs. This is because toxins produced by venomous animals commonly
bind to an alter the function of VGSCs22. There are two general modes of toxin binding to
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VGSCs. Some toxins will inhibit the channel from conducting sodium ions by directly binding to
the PD and blocking the ions from passing through. Such toxins are classified as pore-blockers.
Pore blockers include the pufferfish heterocyclic tetrodotoxin and peptide 𝜇-conotoxins, which
are found in the venom of cone snails14. The other common mode involves toxin binding to the
VSD and preventing the conformational change that results in channel opening and/or
inactivation. Toxins that act through this mechanism are known as gating-modifiers22. Several
gating-modifier toxins have been identified to bind to the VSDs of Nav 1.7 with high affinity and
specificity. There are many different types of these toxins found in nature that have evolved to
bind to the extracellular loop which connects the S3 and S4 helices of VGSCs. One class of
peptide toxins that are found in scorpion venom are the α-scorpion toxins, which bind to this
region and inhibit the channel14. Other peptide toxins from sea anemone venom have been
shown to have the same effect and bind to this S3-S4 extracellular loop of VGSCs as well14.
Since this region of the channel is critical for controlling the gating properties, it makes sense
that peptide toxins from a variety of species have evolved to target their prey by binding to this
region and modifying the gating properties. This region is referred to as the paddle motif, since
it is comprised of an extracellular loop that somewhat resembles a paddle.
One of the most widely studied toxins that is known to bind to and block function of
Nav 1.7 is the tarantula-derived Protoxin-II (ProTxII). ProTxII is an inhibitory cysteine knot (ICK)
toxin which binds to the VSD of Nav 1.7 and inhibits the channel from shifting to the open,
sodium-conducting conformation24. ICK peptides are characterized by their common structural
features. They contain a triple stranded antiparallel β-sheet with a ring forming “cysteine knot”
formed by two disulfide bonds and a third disulfide bond which joins the backbone between
strands (see Figure 2). The inhibitory part of the ICK name refers to the fact that many of these
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Figure 2: Structural alignment of ProTxII and PaTxI 24 13. PaTxI is shown in red, while ProTxII is in blue. The disulfide
bonds are shown explicitly in this representation. The disulfide bonding arrangement is the same for both toxins and
the overall structures are very similar.

toxins have been found to inhibit ion channels25. Therefore, ICK peptide toxins are an invaluable
asset to researchers in the field of rational drug design.
One of the major concerns among those engaged with rational drug design based on
knowledge of natural interactions is: what properties, if any, confer binding specificity? ProTxII is
known to preferentially bind to Nav 1.7, which begs the question of what properties grant the
toxin with this ability26. To gain an insight into the properties of toxins which confer specificity
and/or binding affinity, we can compare the structure and sequence between ProTxII and a closely
related homolog that does not have the same binding partner profile. The study of such gating
modifier toxins and their interactions with VGSCs has applications in the field of rational drug
design.
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Homologues of ProTxII, a strong binder of 𝐍𝐚𝐯 𝟏. 𝟕
The solution state structure of a PaTxI, an NaSpTx3 family tarantula toxin with 86%
homology to ProTxII, has been reported27. It has been shown that PaTxI preferentially binds to
an isoform of mammalian potassium channels instead of sodium channels such as Nav 1.7 or
Nav 1.2 28. Given the sequence homology and the fact that they are both ICK peptide toxins, it is
not surprising that the structures are highly similar (see figure 2). If so, then it is also likely that
binding specificity is purely sequence specific. In other words, there could be a single residue
which is present in ProTxII and not in other closely related homologs which confers binding
specificity towards Nav 1.7. The solution state structure of ProTxII has been reported13, figure 2
shows a structural overlay of the ProTxII with PaTxI. As can been seen, the overall structures of
ProTxII and PaTxI are very similar. Considering the sequences of both, the most significant
difference between the two toxins is the 12th residue24. The 12th residue of ProTxII is a glutamic
acid, while that of PaTxI is alanine. It is highly possible that this single amino acid difference
accounts for the binding specificity of ProTxII towards Nav 1.7. In fact, mutation studies along with
electrophysiology have shown that the 12th residue in these two toxins is crucial for binding
specificity toward Nav 1.724. Various modifications were made to both ProTxII and PaTxI and
IC50 measurements obtained for both Nav 1.7 and Nav 1.2 inhibition (Figure 3). As shown in
figure 3, the residues Ser11, Tyr19 and Arg22 are also important for binding affinity and specificity
towards VGSCs24. In all, the comparison of ProTxII with PaTxI indicates that the binding specificity
in this case is not granted by the general backbone structure of the toxins, but by small
perturbations in the sequence. The general structural architecture of the toxins is no doubt
important for the binding of the toxins to ion channels. However, specificity appears to be
dictated by a small subset of residues.
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Figure 3: The above table shows the various mutations made in ProTxII and PaTxI along with corresponding 𝐈𝐂𝟓𝟎
measurements with 𝐍𝐚𝐯 𝟏. 𝟐 and𝐍𝐚𝐯 𝟏. 𝟕. Table reproduced from29.

Another spider toxin that has been shown to bind to and inhibit Nav 1.7 is huwentoxinIV (HWTX-IV), produced by the Chinese bird spider, Selenocosmia huwena12. HWTX-IV is an ICK
peptide for which the solution state structure has been solved. This peptide toxin has four βturns and 3 disulfide bonds30. This gives the toxin the same disulfide framework as ProTxII, (C1C4, C2-C5, C3-C6). Although both ProTxII and HWTX-IV block Nav 1.7, HWTX-IV does not
favor binding Nav 1.7 over other tetrodotoxin (TTX) sensitive VGSCs as ProTxII does. A study
to investigate the binding of ProTxII and HWTX-IV to repeat II and repeat IV of Nav 1.7 included
the study of how mutations of voltage sensor residues affect the blocking activity12. This is
intriguing, since for a full understanding of the binding between Nav 1.7 VSD and toxins, the role
of residues of both toxins and VSD in binding should be investigated. Considering that an atomic
structure of the binding interface has not been determined, electrophysiological mutation studies
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represent the most detailed information about the mechanism of binding available. It was initially
proposed that both ProTxII and HWTX-IV inhibit activation of Nav 1.7 by binding to repeat II
(DII) and by trapping the voltage sensing helix of the VSD (S4) in the inactive conformation31. The
IC50 of ProTxII and HWTX-IV are in the nanomolar range (0.7 and 22.7 nM, respectively)12. One
of the critical residues of Nav 1.7 for ProTx II binding is Phe813 of the S3-S4 linker in the DII
VSD. However, it is the Glu818 of the S3-S4 linker in DII of Nav 1.7 which is crucial for HWTXIV binding. The F813G mutation resulted in a 9-fold decrease in ProTxII affinity for Nav 1.7, while
it did not significantly affect the affinity of HWTX-IV. Conversely, the E818C mutation decreases
HWTX-IV affinity for Nav 1.7 by 400-fold, while that of ProTx II is only decreased by 4-fold12.
This suggests that there are strong, specific interactions between ProTxII and F813 of Nav 1.7
and HWTX-IV with Glu818 of Nav 1.7, but not vice-versa. Interestingly, F813 is unique to the
Nav 1.7 S3-S4 linker despite otherwise large similarity between sequences of the other VGSC
isoforms in this region26. Therefore, F813 could be one of the major reasons why ProTxII has ~
100 times greater specificity towards Nav 1.7 over the other VGSCs. There are several
hydrophobic residues of ProTxII which could be interacting with F813 of the VSD. It has been
shown that interactions between tarantula toxins and VSDs occur through a membraneanchoring mechanism, in which the toxin binds to the phospholipid membrane first and then the
ion channel32. Therefore, hydrophobic interactions are likely to be important in both toxin binding
with the VSD itself as well as the cell membrane, which could be a prerequisite for channel
binding.
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GpTxI: Alanine Scanning
Interestingly, another tarantula toxin besides ProTxII has been found to have high
selectivity for hNav 1.7 over other VGSC isoforms. The toxin known as GpTxI from the tarantula
Grammostola rosea has been found to also have this high degree of specificity for Nav 1.7
inhibition33. GpTxI is a potent inhibitor of Nav 1.7, with an IC50 of 10 nM, and with selectivity
over Nav 1.5 of 1000X, and with that over Nav 1.4 being 20X33. The solution NMR structure of
GpTxI has been reported, along with a structure-activity relationship profile via alanine scan29.
The alanine scan is a method in which residues are mutated to alanine individually, to see which
residues are critical for binding. Each of the 36 residues of GpTxI was individually mutated to
alanine (excluding the cysteines) and IC50 values against Nav 1.7 were determined. The three
most important residues of GpTxI for Nav 1.7 inhibition are all near the C-terminus: Trp29,
Lys31, and Phe34, as shown by the alanine scan study. However, the specificity was also examined
in this study by measuring the IC50 values of the alanine scan mutants against Nav 1.4 and Nav 1.5
as well.
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Figure 4: Sequnce of GpTx I along with other toxins known to be inhibotors of 𝐍𝐚𝐯 𝟏. 𝟕. Cysteine disulfide pairs
are shown. Table reproduced from29

Interestingly, the position 5 mutation of phenylalanine to alanine improved the selectivity
of GpTxI for Nav 1.7 over Nav 1.4 by 70-fold and that over Nav 1.5 by at least 5-fold. The IC50 of
this mutant did increase in comparison to wild type from roughly 0.09 μM to 0.63 μM29. This is a
good example of the fact that the residues required for potent inhibition may not be the same as
the residues which are important for specificity.
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Figure 5: Table summarizing the effects of position 5 mutations on GpTxI towrds activity on 𝐍𝐚𝐯 𝟏. 𝟕 , 𝐍𝐚𝐯 𝟏. 𝟒
and 𝐍𝐚𝐯 𝟏. 𝟓 29.

In this case, since the residues that are important for potent inhibition are surrounding
Phe5, this may be because the bulky side chain of phenylalanine prevents some of the contacts
made between the residues shown in green in figure 6 and the residues of the VSD. While
hydrophobic interactions are indeed vital for many if not all toxin-VSD binding partners, size and
shape are also crucial factors not only for binding affinity, but for specificity. While labor intensive,
the alanine scan method can yield great insight into the properties of toxin-ion channel binding
and could be vital in the discovery and design of potential drug leads.
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Figure 6: Surface map of GpTx I, illustrating the residues which have been found to be crucial for potent
inhibition of 𝐍𝐚𝐯 𝟏. 𝟕 (shown in green) along with residues important for binding specificity for 𝐍𝐚𝐯 𝟏. 𝟕 (shown in
magenta). Reproduced from34.

While the alanine scan does provide valuable information about the toxin-channel binding
interface, a more rigorous approach must be used if one pursues a higher level of resolution. Of
course, having an atomic-resolution structure of the docked complex is among the most desirable
assets to attain if attempting to find information on a binding interface. However, this is often
very difficult to achieve in practice. Even the current structures the Nav 1.7 in complex with
ProTxII have a poorly resolved binding interface, which is not at atomic resolution3. Besides
obtaining an atomic-resolution structure by x-ray crystallography, NMR or cryo-electron
microscopy, another way to gain a higher level of detail about the binding interface than can be
achieved from an alanine scan alone is the method of multi attribute positional scanning (MAPS)34.
MAPS could be thought of as an advanced form of the alanine scan. Each residue is sequentially
mutated to several representative amino acids of each chemical characteristic (i.e., hydrophobic,
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basic, acidic, etc.). This method clearly requires the synthesis of many mutants, much more than
that of the alanine scan method. However, the higher level of binding information that could be
gained is likely to be worth the extra work. Murray et al34 used the MAPS method to investigate
the binding between GpTxI and Nav 1.7. This study has helped identify several GpTxI residues
that could be directly involved with Nav 1.7 binding. For example, 9 of the toxin’s basic or
hydrophobic residues were mutated to glutamate, resulting in a 5-20X reduction in Nav 1.7
binding34. The MAPS method is not only useful for obtaining information on which residues are
important for binding, but also for specificity. For instance, the R18 residue of the toxin is on the
solvent exposed surface of the toxin and is part of what is believed to be the binding site. Mutation
of R18 to a lysine not only decreases the IC50 from 10nM to 1.6 nM, but intriguingly increases
the selectivity of GpTxI for Nav 1.7 over Nav 1.4 from 20X to over 300X34. Being that arginine
and lysine have the same charge, this drastic change could be due to the shape difference that
results in a better fit bound state. This illustrates some of the factors that must be considered
when analyzing a binding interface without explicit knowledge of the molecular structure. In
summary, we know that toxin-VGSC interactions are a complex phenomenon. Electrophysiology
studies using mutations for comparison to wild type have been the major driving force of
understanding these interactions. However, these functional studies can be limiting in the amount
of biophysical information that can be gathered. The residues important for functional activity are
one piece of the puzzle. If one is interested in rational drug design based on knowledge of ion
channel-toxin interactions, more information is needed. A technique such as NMR spectroscopy
could be used to determine the distances between residues and the respective orientations of
binding. To gain a deeper insight into these interactions, one can use solution or solid-state NMR
spectroscopy-based titration experiments along with a variety of other types of multidimensional
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NMR experiments of a VGSC/toxin complex. With the knowledge of toxin interactions that was
derived from electrophysiology approaches, we aim to investigate the molecular details of toxin
binding to Nav 1.7 using solution state NMR spectroscopy.

Tsu1.1: A Novel Terebrid Toxin
Toxins produced by venomous animals provide a broad and effective library for studying
drug target-ligand interactions. Based on the example of NaV 1.7, it is likely that toxins could be
found in nature that target many membrane proteins involved in different pathologies. Although
this is of course not a guarantee, it seems certain that a vast number of toxins targeting many
different membrane receptors or ion channels have not yet been discovered or characterized.
Studying and characterizing toxins from various species is therefore a key interest in the field of
rational drug design. In this study, we have solved the structure of a newly characterized terebrid
marine snail toxin, Tsu1.1. Terebrids are a family of venomous marine gastropods in the Conoidea
superfamily, which includes cone snails. Tsu1.1 has been shown to be induce an increase in food
intake in drosophila8. This terebrid marine snail toxin is in the framework I group of conotoxins.
Although Tsu1.1 is not a conotoxin, (it is a teretoxin, being that it is produced by a terebrid) it is
classified under the framework I group of conotoxins due to the cysteine disulfide bonding
arrangement, which is the same in framework I conotoxins. This framework is defined based on
the primary sequence arrangement of cysteines. If the first two cysteines are adjoining, while the
last two are separated by one or more amino acids (CC-C-C, where a dash refers to one or
more amino acid(s) other than cysteine), the conotoxin is designated as a framework I conotoxin.
Framework I conotoxins are known to bind to adrenergic and nicotinic acetylcholine receptors.
However, Tsu1.1 may also have other targets. As a first step towards structure-activity and
mechanistic binding studies, we set out to obtain an atomic-resolution structure of this toxin.
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Binding studies with various targets and structural characterization of a ligand-target pair for
rational drug design would be carried out in future studies.

Tsu1.1 Structural Investigation: Procedures
In the lab of our collaborators, Tsu1.1 was produced via FMOC synthesis and oxidative
refolding of disulfide bonds, followed by reverse-phase HPLC purification. The resulting powder
was dissolved to a concentration of ~150μM. This concentration was estimated based on the
mass of the powder and molecular weight of the toxin, since the toxin does not have any
tryptophan residues for which the UV/VIS absorbance at 280 nm can be measured.

Figure 7: Sequence of Tsu1.1 aligned with other members of the framework I conotoxins.

The Tsu1.1 prepared at 150 μM was used for solution-state NMR experiments in 5 % D2 O
and100 μM DSS (trimethylsilylpropanesulfonate) was used for the reference chemical shift.
The pH of the solution was measured to be ~5.0, no additional buffers or salts were added. The
experiments were all run at 4°C. TOCSY and NOESY were performed on a Varian 600MHz
spectrometer, while the 13C HSQC was performed on an 800MHz Bruker instrument. The 13C
HSQC experiment was done using natural abundance 13C alone, so the experiment was run for
~3 days in order to obtain a spectrum with sufficient signal, whereas for the TOCSY and
NOESY experiments adequate spectra were obtained overnight. Data was processed and
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phased using NMRPIPE35. Analysis and resonance assignments were performed using the
CCPNMR analysis program36. The resulting NOE and chemical shift data were fed into the
XPLOR-NIH program for simulated annealing structure calculations37.

Tsu1.1 Structural Investigation: Results
In this study, TOCSY (Total Correlation Spectroscopy), NOESY (Nuclear Overhauser Effect
Spectroscopy) and HSQC (Heteronuclear Single Quantum Coherence) NMR experiments were
performed on Tsu1.1 and provided sufficient information to obtain the three-dimensional
structure of the peptide. These NMR techniques are discussed in more detail in Chapter 4. For
small peptides, NMR experiments are usually collected at lower temperatures to reduce the
extent of thermal motion and thereby increase the sensitivity of NOE signals in an NMR
experiment. Therefore, TOCSY, NOESY, and 13C HSQC experiments were all performed on
Tsu1.1 at 4°C. to make assignments and determine the structure.
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Figure 8: Overlay of TOCSY and NOESY of Tsu1.1 performed on a Varian 600MHz spectrometer at 4°C.
TOCSY is shown in blue and the NOESY in green.This shows a portion of the side-chain region which contains
resonances which represent correlations between side-chain Hαs and Hβs with amide protons. Hα and Hβ
chemical shift values for most amino acids are typically between 4 and 1 ppm, while that of amide protons are
typically between 7 and 9 ppm.

Upon making resonance assignments of the Tsu1.1 NMR spectra, the 13C and 1H chemical
shift data was fed into the TALOS38 program for prediction of the dihedral angles of the Tsu1.1
peptide backbone. TALOS generates a list of dihedral angles for the residues in which the 13C
chemical shift data are available. The list of dihedral angles were then used as a restraint in a
simulated annealing structure calculation. The XPLOR-NIH program supports dihedral angle
restraints along with NOE restraints which were the two types of restraints used for the
structure calculation of Tsu1.1. The resonance assignments were made using the CCPNMR
program, which generated a list of NOEs and the corresponding intensities based on the peak
assignments.
After obtaining a list of NOE restraints from CCPNMR and a list of dihedral angle
restraints from TALOS, the lists were converted to XPOLR-NIH format via Python scripts. The
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files produced by execution of the Python scripts were directly fed into the XPLOR-NIH
configuration file, which executes the structure calculation. The initial structure calculation was
executed to generate 20 structures. It was performed using a simulated annealing simulation
which begins at 3500°C and ends at 25°C. The simulation was run over the course of 100ps in
1000 steps. The average backbone RMSD between the 20 structures was calculated to be roughly
2.5 Angstroms.

Figure 9: Overlay of seven out of the twenty structures in the initial NMR ensemble of Tsu1.1 solved using
XPLOR-NIH. The total ensemble has an average RMSD of 2.5 Å. It appears that the members of the ensemble
have overall structural similarity, however it would be desirable to lower the RMSD with refinement structure
calculations.

The lower the RMSD of an NMR ensemble, the more accurate is the structure, unless
one is studying an intrinsically disordered protein. The RMSD is typically calculated in protein
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NMR structures as the RMSD between backbone C𝛼 atoms from between one member of the
ensemble and the others. This is the case with the current XPLOR-NIH calculation of Tsu1.1.
Tsu1.1 has two disulfide bonds, the NOE data indicates that the bonding pattern is Cys6-Cys12
and Cys7-Cys18. The structure calculation also indicates that this is the most realistic possibility
of disulfide bonding in Tsu1.1.

Figure 10: Average structure of Tsu1.1 from the ensemble structure calculation showing the cysteine side chain
orientation. The Cys6-Cys12 (left side) and Cys7-Cys18 (right side) pairs are positioned in the proper orientation
for disulfide bonding. Additionally, there are NOE peaks between 𝐂𝜷 atoms from Cys6 and Cys12 along with Cys7
and Cys18. These results indicate that this is the disulfide bonding pattern of Tsu1.1.

In order to improve the accuracy of the Tsu1.1 NMR ensemble, we have incorporated
additional constraints for the disulfide bonds. XPLOR-NIH allows disulfide constraints to be
added to the configuration file for a simulated annealing simulation. We had first performed the
simulated annealing calculation (with NOE and dihedral restraints) without disulfide restraints to
allow the structure to properly relax and to avoid obtaining high energies. Once the first
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ensemble was generated, then the calculation was performed again (using the average ensemble
structure of the first calculation as reference coordinates) with the additional disulfide bond
restraints. The structure calculation was performed in the same way as before, except this time
with the additional disulfide bond restraints. The 20 structures generated from this calculation

Figure 11: Block of the XPLOR-NIH configuration script used for the simulated annealing calculation of Tsu1.1
with the inclusion of disulfide bond restraints for Cys6-Cys12 and Cys7-Cys18.

have an average backbone RMSD of 1.8 Å. The initial structure calculation of Tsu1.1 without the
additional disulfide restraints had an average ensemble backbone RMSD of 2.5 Å. Therefore, the
disulfide restraints likely improved the accuracy of the structure calculation. The disulfide
restrained structure calculation also resulted in a lower number of violations of the NOE
potential terms compared to the original calculation. Violations occur when the potential energy
terms exceed some defined threshold value during any point in the simulated annealing simulation.
While we were not able to get rid of all the violations, a decrease in the number of violations is
a good indicator of an improvement in the structure calculation. The original structure calculation
resulted in 27 violations over 10 structures. The disulfide bonded simulation resulted with less
violations (20) over 10 structures.
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Violation %
100
100
90
90
80
80
70
70
60
60
60
60
50
50
40
30
30
20
20
20
20
10
10
10
10
10

Violation Amount
1.26
1.91
1.38
1.34
1.24
0.77
0.68
1.25
1.74
1.15
0.88
0.99
0.75
0.77
0.68
0.60
0.76
0.53
0.73
0.67
1.34
0.51
0.65
0.55
0.52
0.64

Restraint Name
Glu8 HA-Thr15 HN
Val3 HA-Pro10 HB1
His14 HA-Ala2 HN
Thr20 HA-Cys12 HN
Val11 HA- Val3 HN
Glu4 HA-Cys18 HN
Glu4 HN-Glu4 HB2
Ser16 HN-Glu4 HG1
His14 HA-His14 HE1
His14 HE1-Ser16 HB2
Val11 HN-Cys12 HA
Ser16 HN-Glu8 HB1
Val3 HB-Glu8 HN
Glu5 HN-His14 HB2
Val3 HN-Val3 HG2
Cys6 HB2-Asn9 HN
Cys12 HN-Val3 HG1
Cys7 HA-Cys6 HN
Glu4 HN-Val3 HG2
Cys12 HN-Val3 HB
Cys7 HN-Cys12 HB2
Val11 HA-Val11 HN
Cys7 HN-Cys7 HA
Ala2 HB-Ala2 HN
Lys13 HN-Lys13 HE2
Thr20 HN-Val11 HN

Figure 12: Table of violations in the NOE potential energy which occurred in the original structure calculation of
Tsu1.1. The violations list is the total violations over 10 structures calculated in the ensemble. The violation %
indicates in what percentage of the structures the violation is present, the violation amount is the value in distance
(Å) of the harmonic NOE potential and the name of the restraint comes from the original NOE assignments.
There is a total of 27 violations in this ensemble, 12 of which are below 50% violation.

One way that an NMR ensemble can be improved in terms of structural accuracy is to
use a water refinement calculation. In such a structure calculation, the NOE and dihedral angle
(and others if applicable) restraints are fed into the structure calculation program which includes
a force-field for implicit water solvation. This allows for a more accurate physical system which
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includes the potential energy terms of the solvent/protein interactions. Although this may not be
as accurate as explicit water models, the implicit water system is computationally inexpensive and
typically provides improvements in structural accuracy (i.e., lower RMSD values for an NMR
ensemble). In this study, we use the XPLOR-NIH supported EEFX force-field for the implicit
solvation of Tsu1.1 in structural calculations39. The EEFX simulation on Tsu1.1 was performed
using the Tsu1.1 structure from the previous structure calculation as the reference coordinates.
The structure was then refined using the NOE and dihedral restraints as potential energy terms
along with the implicit solvation terms of the force-field. The water refinement structure
calculation resulted in 100 structures in the ensemble with the 10 or 20 lowest energy structures
considered as the final structural bundle. Performing the calculations and analysis in this way helps
mitigate the inclusion of high-energy (or low population) states which could be generated in the
implicit solvation calculation. The average RMSD of the 20 lowest energy members of the Tsu1.1
ensemble generated by the EEFX calculation is 1.2 Å, a significant improvement compared to the
original structure calculation without using the implicit solvation. As can be seen in Figure 13, the
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ten lowest energy members of the refined Tsu1.1 ensemble overlap well, indicating a high degree
of structural convergence. The disulfide bond restraints were also added

Figure 13: Ten lowest energy structures of the EEFX implicit water structure calculation of Tsu1.1 using XPLORNIH. It is clear that the RMSD between structures of the ensemble significantly decrease compared to that for the
original structure calculation.

to the refinement calculation explicitly. We therefore suppose that the final ensemble of Tsu1.1
generated with the EEFX calculation along with disulfide bond restraints represents an accurate
structure of Tsu1.1. Further investigation of the binding properties of Tsu1.1 could potentially
complement these structural studies.
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Figure 14: Structure of Tsu1.1 with side chains shown. Cys-7 Cys-18 disulfide pair can be seen in the bottom
portion of the image.

The final water refined EEFX structure calculation resulted with 16 violations over 20
structures. Out of the 16 violations in the final structure calculation, 6 have a violation % of 30
or less. This means that they are not very strong violations. It is not always necessary to remove
all violations, since some violations are fundamentally related to dynamic processes which occur
in proteins. There are many cases in which removal of NOE restraints which give violations will
result in higher energy structures with higher ensemble RMSD for a protein NMR structure
calculation40. Therefore, one must achieve a balance between logically analyzing the NOE data
and violations together in a systematic way to determine which NOEs might not be true and
which violations should be kept as restraints in the refinement structure calculations. Additionally,
a spectrum with a high noise level could interfere with the NOEs such that their true intensity is
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masked. Therefore, one must be careful to properly distinguish between true NOEs and noise as
well as determine the necessary number of scans that should be run in the NMR experiment such
that the noise is sufficiently low. Generally, the higher the number of scans performed in an NMR
experiment, the more the signal to noise ratio will improve.

Violation %
100
100
100
100
100
95
95
95
95
95
30
20
5
5
5
5

Violation Amount
1.90
1.61
1.17
0.98
0.79
0.53
0.73
0.67
1.19
1.54
0.61
0.54
1.15
0.88
0.95
1.09

Restraint Name
His14 HA-His14 HE1
Val11 HA-Val3 HN
Glu8 HA-Thr15 HN
Cys6 HN-Cys18 HB1
Pro19 HG1-Val11 HN
Lys13 HA-Lys13 HN
Ser16 HN-Glu8 HB1
Cys12 HN-Val3 HB
His14 HA-Ala2 HN
Cys7 HN-Cys12 HB2
Glu4 HN-Glu4 HB2
Thr20 HA-Val11 HN
Val3 HN-Val3 HG2
Glu8 HN-Cys12 HA
Cys12 HN-Val3 HG1
Val3 HA-Pro10 HB1

Figure 15: Table of violations if the NOE potential energy which occurred in the final water refinement EEFX
structure calculation of Tsu1.1. There is a total of 16 violations in this ensemble of 20 structures, as opposed to
the original structure calculation which had 27 violations over 10 structures. Additionally, 6 out of the 10 violations
have a violation % of 30 or less.
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The solution-state NMR structure of Tsu1.1 reported here was compared to the
structure of a framework I conotoxin for which the structure is available, called Bu1A41.
Although they are both in the framework I family, the structure of Tsu1.1 is quite different to
that of Bu1A, as can be seen in the figure below. However, it is clear from the sequence
alignment shown below that the primary sequences are quite different. The cysteines and one
proline (Pro10 of Tsu1.1) are the only residues which give an identical match in the sequence
alignment of Tsu1.1 with Bu1A. Therefore, it is not a surprise that the structures have some
major differences. While both toxins have a helical region, the helix of Tsu1.1 has a wider pitch
than that of Bu1A.

Figure 16: Structural alignment of Tsu1.1 (purple) and Bu1A (blue) with disulfide bonds explicitly shown. Despite
that these are both in the framework I cysteine arrangement, the structures are quite different. For instance, the
helical portion of Tsu1.1 has a wider pitch than that of Bu1A. It is not surprising that the structures are quite
different, however, because the primary sequences are not similar.
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Figure 17: Primary sequence alignment of Tsu1.1 with the framework I conotoxin, Bu1A using the Clustal Omega
program42. It is apparent from the alignment that the primary sequences do not have much similarity apart from
the cysteine framework.

In summary, we report the solution state NMR structure of Tsu1.1 with an ensemble
backbone RMSD of 1.2 Å. The disulfide bond arrangement was found to be Cys6-Cys12 and
Cys7-Cys18. The structure of Tsu1.1 is quite different from that of the homolog BuIA, a
framework I conotoxin for which the structure has been reported41. However, despite the fact
that BuIA and Tsu1.1 are both classified according to the framework I family of conotoxins, the
primary sequences of these two toxins are quite different. Therefore, it is not very surprising
that the structures are quite different. One further study that would be useful to be done on
Tsu1.1 would be to determine direct targets of Tsu1.1 in vivo using a binding screen method
such as coimmunoprecipitation (Co-IP). Being that framework I conotoxins are known to
interact with adrenergic and nicotinic acetylcholine receptors, Co-IP could be performed using
lysed cells which express these receptors along with the respective antibodies and Tsu1.1.
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Chemical Shifts Table and Structure Statistics of Tsu1.1:
Table 1: Tsu1.1 Chemical Shift Table

Atom
2Ala-NH
2Ala-Ha
2Ala-Hb
2Ala-Ca
2Ala-Cb
9Asn-NH
9Asn-Ha
9Asn-Hb
9Asn-Ca
9Asn-Cb
6Cys-NH
6Cys-Ha
6Cys-Hb1
6Cys-Hb2
6Cys-Ca
6Cys-Cb
7Cys-NH
7Cys-Ha
7Cys-Hb1
7Cys-Hb2
12Cys-HN
12Cys-Ha
12Cys-Hb1
12Cys-Hb2
12Cys-Ca
12Cys-Cb
18Cys-HN
18Cys-Ha
18Cys-Hb1
18Cys-Hb2
18Cys-Ca
18Cys-Cb
5Glu-NH
5Glu-Ha
5Glu-Hb1
5Glu-Hga
5Glu-Hgb
5Glu-Ca
5Glu-Cb
4Glu-NH
4Glu-Ha
4Glu-Hb1
4Glu-Hb2
4Glu-Hga
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Chemical Shift Value (ppm)
9.021
4.225
1.436
57.046
18.726
8.307
3.637
3.134
51.558
41.370
7.666
4.079
2.116
1.961
57.525
32.928
7.329
3.850
3.086
2.917
8.277
4.009
2.946
3.187
59.309
42.070
7.579
4.001
3.322
2.409
59.309
51.593
7.559
4.324
1.932
2.335
2.327
62.117
30.605
8.240
4.222
1.122
1.966
1.966

4Glu-Hgb
4Glu-Cb
8Glu-HN
8Glu-Ha
8Glu-Hb1
8Glu-Hb2
8Glu-Hga
8Glu-Cg
17Gly-NH
17Gly-Ha1
17Gly-Ha2
17Gly-Ca
14His-NH
14His-Ha
14His-Hb1
14His-Hb2
14His-He1
14His-Ca
13Lys-NH
13Lys-Ha
13Lys-Hb
13Lys-He1
13Lys-He2
13Lys-Cb
13Lys-Ce
19Pro-Ha
19Pro-Hb1
19Pro-Hb2
19Pro-Hga
19Pro-Cb
10Pro-Ha
10Pro-Hb1
10Pro-Hb2
10Pro-Hd1
10Pro-Cb
16Ser-NH
16Ser-Hb1
16Ser-Hb2
16Ser-Cb
15Thr-NH
15Thr-Ha
15Thr-Hg
15Thr-Ca
15Thr-Cg
20Thr-NH
20Thr-Ha
20Thr-Hg
21Thr-NH
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1.966
32.479
8.477
4.366
1.890
2.014
2.256
36.629
8.031
3.716
3.716
46.279
7.811
4.201
3.146
2.945
8.709
59.794
8.673
4.206
2.490
2.901
2.902
34.249
42.064
4.507
1.973
2.283
1.296
32.591
4.257
1.897
2.266
3.888
31.641
7.847
3.920
3.927
62.265
7.873
4.106
1.196
63.627
21.925
8.239
3.925
1.035
8.271

21Thr-Ha
21Thr-Hb
21Thr-Hg
21Thr-Ca
21Thr-Cb
21Thr-Cg
3Val-NH
3Val-Ha
3Val-Hb
3Val-Hg1
3Val-Hg2
3Val-Ca
3Val-Cb
11Val-NH
11Val-Ha
11Val-Ca

4.460
4.166
0.906
63.662
70.915
21.305
8.011
3.999
2.406
2.272
2.014
63.679
32.824
8.878
4.247
56.729

Table II: Structural Statistics of Tsu1.1
Quantity

Value

Total distance restraints in final refinement simulation

85

Intra-residue
Sequential

40
6

Medium (2-4 residues apart)

10

Long range

29

Backbone RMSD of 20 lowest energy structures from refinement calculation
Number of dihedral angle restraints used in refinement simulation

1.5 Å
18

Ramachandran analysis:
Number of residues in favored region

98%

Number of residues in allowed region

2%
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Table III: Average values for potential energy terms from water refinement structure
calculation of 20 lowest energy structures
Name

Energy

RMSD

Violations

Total

1774.37

2.098

34.1

NOE

502.85

0.489

11.1

ANGL

197.89

1.585

8.3

BOND

58.15

0.014

2.5

CDIH

51.81

6.600

5.5

IMPR

68.24

1.802

5.0
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Expression, Purification and Refolding of 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II:

Gene Design:

The gene for human Nav 1.7 VSD-II was obtained from the Uniprot database43 under the
gene name SCN9A. The database provides a predicted topology layout of the structural
components of many ion channels of which the structures or the structures of homologous
proteins have been solved. We chose the four TM helices S1-S4 of the repeat II in the channel
as the sequence of interest. This was largely due to the known toxin-binding properties of repeat
II. Twelve residues were added on each side of the VSD, the first of which flank the intracellular
loop preceding the N-terminal end of S1 and the last of which flank the intracellular loop after
the C-terminal end of S4, in between S4 and S5. We suspect that this addition of residues on
both ends of the VSD would increase the stability and increase the likelihood of proper refolding
of the VSD in future experiments. The gene was codon optimized for E. coli and ordered from
Invitrogen™. The gene was designed with endonuclease sites at either end in such a way that we
could ligate directly into an inclusion body fusion tag construct that was thought to help boost
expression levels. This is because the direct expression of Nav 1.7 VSD had been attempted using
pET-28 and gave little to no expression after many optimization trials.
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Figure 18: Sequence of 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II used in this study. Blue residues indicate a TM helix, while resides shown
in red are intracellular or extracellular loops.

Molecular Biology Procedures:
Modifications made to the pSW02 expression vector were performed using a quickchange site directed mutagenesis PCR kit purchased from Agilent ™. Primers were purchased
from Thermo Fischer Scientific ™. The resulting PCR products were sent to Genewiz ™ in South
Plainfield, NJ for sequencing. Analysis of the DNA sequences was performed using the Bioedit
™ program. The successfully mutated plasmids were transformed into NEB-5α (New England
Biolabs ™) competent E. coli cells for mini-prep plasmid DNA purification.

Expression and Purification Procedures:
Expression of Nav 1.7 -repeat II VSD was performed in the pSW02 expression vector,
with a TrpΔLE fusion partner. Fusion proteins of TrpΔLE have been shown to be incorporated
into inclusion bodies7. Insoluble inclusion-body based expression for this system was chosen
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because direct expression of the protein into the membrane showed little to no protein levels.
The purification is performed using IMAC as the fusion protein has an N-terminal 6XHIS tag at
the end of the TrpΔLE. The IMAC purification in this case was performed with detergent present,
otherwise the fusion protein will not be soluble. C43 E. coli cells were grown in M63 medium (as
NMR experiments are one of the major end goals of this project) at 37°C and induced at an
optical density of 0.4 with 1mM IPTG and grown overnight at 37°C. Cells were then lysed in 50
mM Tris HCl pH 8.0, 150mM NaCl, 0.1% DNaseI and 1mg/mL lysozyme, followed by sonication.
Insoluble material was then collected by centrifugation at 25,000Xg. Inclusion bodies were
washed using 10 mL 1% triton-X-100 in 50 mM Tris-HCl pH 8.0, resuspended by sonication and
spun down again at 25,000Xg. The resulting pellets were washed with 20 mL dH2 O and the same
process was repeated. The final inclusion body pellets were solubilized using ~80 mL 8 M urea
with 1% n-lauryl sarcosine and resuspended by sonication. Volume measurements noted above
correspond to inclusion bodies produced from 2 L of cultured E. coli cells. The resulting solution
was allowed to incubate with shaking overnight at room temperature and then used for IMAC
purification using Ni-NTA resin. IMAC purification of the fusion protein was performed using a
wash buffer containing 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 20 mM imidazole and 1% n-lauryl
sarcosine. Elution buffer for the IMAC was prepared using 50 mM Tris-HCl pH 8.0, 100 mM
NaCl, 500 mM imidazole and 1% n-lauryl sarcosine. The fusion protein was purified using a gravity
column, washed with 3X1 mL of wash buffer and eluted with 10X0.5 mL of elution buffer. The
resulting elution fractions were analyzed by SDS-PAGE and pooled accordingly for the cleavage
reaction step.

Protein Cleavage Procedures:
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Thrombin cleavage was performed using ~50 U of thrombin in 1% n-lauryl sarcosine with
25 mM Tris-HCl pH 8.0, 150 mM NaCl at room temperature for 18 hours. Bovine thrombin was
purchased from Sigma ™ as lyophilized powder.
Nickel (II) catalyzed cleavage was performed using 2 mM NiCl2 in 1% SDS. The fusion
protein was pooled from IMAC purification and dialyzed into (roughly 10 mL against 1 L) 2 mM
NiCl2 overnight and then the reaction was allowed to continue for an additional 24 hours at
45°C.
Hydroxylamine cleavage was performed using 1.1 M hydroxylamine in 1% n-lauryl
sarcosine and 6 M guanidine-HCl at 45°C for ~72 hours. The IMAC purified fusion protein was
pooled and added to a 2X solution of hydroxylamine containing 2.2 M hydroxylamine, 2% n-lauryl
sarcosine, 6 M guanidine HCl with pH adjusted to ~9 with NaOH. Guanidine-HCl was also added
to the IMAC pool to a concentration of 6 M. The IMAC pool was then combined with the same
volume (1:1) of the 2X hydroxylamine solution described above. Typically, the reaction volume
was ~25 mL. Following the reaction, it was discovered that the cleaved reaction products must
be dialyzed first into 8 M urea with 1% SDS after the reaction, before dialysis against a detergent
alone. If this step is skipped, the VSD will precipitate. Therefore, the reaction products (~25 mL
reaction scale into 1 L dialysis buffer) were dialyzed into 8 M urea with 1% SDS overnight and
the next day the urea was removed by using 1% SDS as the dialysis buffer. To remove the
unreacted fusion protein, size exclusion chromatography (SEC) was performed using a Superdex200 10/300 column from GE ™. SEC buffer used was 1% SDS with 25 mM Tris-HCl, pH 8.0.

Refolding Procedures:
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DMPC (dimyristoyl phosphocholine) was purchased from Avanti ™ as a solution of
25 mg/mL in chloroform. The amount of solution needed for each experiment was dried under
nitrogen stream prior to use. The dried DMPC was then resuspened in pentane (to help remove
residual chloroform) and dried again under nitrogen stream. The solid film of DMPC was directly
used to reconstitute the VSD.
DMPC was added to the cleaved VSD in 1% SDS with a 1:300 protein: lipid molar ratio.
The resulting solution was dialyzed against water for roughly 8 days, with daily buffer exchange
cycles. After dialysis, the solution is filtered using a 0.2μm syringe filter. The resulting solution is
used for analytical and binding experiments.

Purification of Recombinant Protoxin II Procedure:
ProTxII was recombinantly expressed based on a published protocol from the Blumenthal
lab15 with minor modifications. We began by expression of the ProTxII as a maltose binding
protein (MBP) fusion protein using a pMAL expression vector in BL21(DE3) competent E. coli
cells as described in the literature. The cells were lysed via sonication in 50 mM Tris HCl pH 8.0,
150 mM NaCl, 0.1% DNaseI, 1mg/mL lysozyme and 1 mM PMSF. Fusion proteins were purified
using Ni2+ affinity chromatography. The purification was performed using a gravity column. 50
mM Tris-HCl pH 8.0, 150 mM NaCl, 20 mM imidazole was used as the wash buffer and 50 mM
Tris-HCl pH 8.0, 150 mM NaCl, 400mM imidazole as the elution buffer. The fusion protein was
allowed to bind to the Ni NTA resin for ~30 minutes. After collection of the flow through, the
resin was washed with 3X1 mL wash buffer and eluted with 10X0.5 mL elution buffer. The
fractions were analyzed by SDS-PAGE and pooled accordingly. The IMAC pool (typically ~4 mL)
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was directly used for the refolding. The refolding process began with a complete reduction step.
The disulfide bonds were reduced using 5 mM DTT for 18 hours at 4°C. Subsequently, fusion
proteins were dialyzed against 1 L of 2.5 mM reduced glutathione for 18 hours. The solution was
removed from dialysis and then oxidized glutathione was added dropwise to a concentration of
0.5 mM. The solution containing oxidized and reduced glutathione was then incubated for 72
hours at 4°C. This procedure provided for proper formation of disulfide bonds. The folded
ProTxII was then dialyzed against 1L of 50 mM ammonium bicarbonate and cleaved from the MBP
using enterokinase (New England Biolabs ™). The resulting solution was purified by HPLC using
a semi-preparative C18 column with a 20-70% acetonitrile gradient over 30 minutes. Peak
fractions were collected and analyzed by MALDI mass spectrometry. Fractions containing ProTxII
were lyophilized and stored as powder until use.

Analytical Methods Procedure:
1

H NMR experiments in this study were performed using a 600MHz Varian ™

spectrometer. All experiments were done at 25°C and using 5% D2 O. Experiments were
acquired using the WET water suppression pulse sequence44. Proton 90° pulses were calibrated
prior to each acquisition. Mass spectrometry experiments were performed using a Bruker ™
Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) mass spectrometer. αCyano-4-hydroxycinnamic acid was used for the application of mass spectrometry samples to
MALDI experiments performed in this study using an ultra-thin layer method as published45.
Microscale thermophoresis (MST) was performed using a NanoTemper ™ instrument and
resulting data were processed using NanoTemper and Palmist binding data analysis software.
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Fluorescently labeled ProTxII was prepared by incubation of the HPLC-purified toxin with AlexaFlour 488 ™/NHS linked dye for ~30 minutes at room temperature with 25 mM HEPES pH 8.0.
The reaction products were purified using a G25 desalting column. Resulting fractions were
analyzed via MALDI mass spectrometry for labeling efficiency. Upon observation of a mass shift
of the toxin of roughly 500 Daltons, corresponding fractions of labeled toxin were used for MST
experiments. Nav 1.7 VSD-II in DMPC solution was titrated into 50 nM of labeled ProTxII. A
concentration of roughly 35 μM VSD was used in the first titration point and was subsequently
diluted 2-fold in each of the remaining 15 titration points (16 total titration points were used).
“Blank” DMPC solution (without VSD) was prepared using the same amount of DMPC typically
used for a VSD refolding preparation (~40 mg) solubilized in 1% SDS and dialyzed against Millipore
™ water for roughly 1 week.

𝐍𝐚𝐯 𝟏. 𝟕 VSD in Bicelles and Micelles Procedure:
Nav 1.7 VSD-II was prepared in DMPC solution as described in the refolding procedures
section. Dihexanoyl-phosphocholine (DHPC) purchased from Anatrace ™ was directly added to
the DMPC solution containing VSD. Nav 1.7 VSD-II in micelles was prepared by extracting the
VSD in DMPC solution with 1.6% lyso-myristoyl phsophoscoline (LMPC) purchased from
Anatrace ™. Extraction was performed by incubation of the VSD in DMPC solution with LMPC
for ~2 hours at 4°C while shaking. The resulting solution was centrifuged at 100,000Xg for 1
hour and supernatant was dialyzed against 75 μM LMPC to remove excess DMPC.

Fusion Protein Cleavage: Results
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To cleave the TrpΔLE fusion tag from the VSD, we have put a thrombin cleavage site in
between the N-Terminus of Nav 1.7 -repeat II and the C-terminus of TrpΔLE. The thrombin
catalyzed cleavage of the fusion protein was attempted in various conditions. After analysis of the
products by SDS-PAGE and MALDI MS, we have concluded that the enzymatic cleavage is not
able to work with this system.

TrpΔLE/VSD Fusion
pH 8.5 0.5M NaCl

pH 8.5 1M NaCl

pH 9.5 1M NaCl

pH 9.5 0.5M
NaCl

pH 8.5 10%
Glycerol

pH 9.5 10%
Glycerol

uncleaved

Protein ~29kDa

Figure 19: Thrombin cleavage of the 𝐍𝐚𝐯 𝟏. 𝟕 −domain II/Trp-Delta-Leader fusion protein under various
conditions. The mass of the fusion protein is 29.05kDa, while the cleaved product is expected to be 15.1kDa.

Our hypothesis is that the reaction was unsuccessful due to the cleavage site not being
accessible to the enzyme. Being that Nav 1.7 VSD has a large hydrophobic content with four
transmembrane helices, we use detergent to help solubilize our fusion protein product. In this
case, we had used n-lauryl sarcosine as the detergent. We suspect that the thrombin cleavage
site is being blocked from thrombin by either a part of the n-lauryl sarcosine micelle, or by the
structure that the protein is adopting in the detergent micelles. To solve this problem, we had
investigated literature that has been reported regarding non-enzymatic chemical catalyzed
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cleavage of peptide bonds. It had been reported that nickel II catalyzes hydrolysis of peptides at
the sequence XTKHI between X and T, where X is any amino acid46.
To exchange the sequence of the thrombin site for the sequence of the Ni2+ catalyzed
cleavage site, we performed mutagenesis PCR on the pSW02 vector which codes for our fusion
protein. We had also added another type of chemical cleavage site to the vector in
consideration of the possibility that the Ni2+ catalyzed peptide cleavage is unsuccessful.
Hydroxylamine based chemical peptide cleavage works by a nucleophilic substitution
mechanism resulting in the cleavage of peptides between asparagine and glycine47. We are also
able to perform these chemical cleavage reactions under harsh denaturing conditions, which is
practical when working with inclusion bodies48.

Figure 20: Schematic design of the 1.7D2-Trp-Delta-Leader fusion protein with the nickel (II) catalyzed cleavage
site (above). The chromatogram we obtained from DNA sequencing shows that our PCR mutagenesis reaction
was a success, the overlapped sequences correspond to the inserted 𝐍𝐢𝟐+ cleavage site.
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The Ni2+ catalyzed cleavage was performed using n-lauryl sarcosine as the detergent
which solubilizes the fusion protein and it was observed that a substance was precipitating out
of the solution. Upon testing a control, we found that it must be n-lauryl sarcosine and Ni2+
forming an insoluble salt. To bypass this issue, we had to switch to a different detergent that
will remain soluble with Ni2+ . A solubility test was performed, and we found that SDS remains
soluble with 2 mM Ni2+ .

Figure 21: 2 mM 𝐍𝐢𝟐+ with 1% n-lauryl sarcosine (left) and 2 mM 𝐍𝐢𝟐+ with 1% SDS (right).

The purification of the fusion protein from inclusion bodies was successful upon
switching the detergent from n-lauryl sarcosine to SDS. We performed the reaction and a
precipitate formed over the course of the reaction, which we had hoped was one of (or both
of) the cleaved fusion partners. However, after SDS-PAGE analysis (Figure 22) of the products,
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we can see that the cleavage reaction was inefficient. We suppose that this inefficiency could be
due to the inability for the Ni2+ ion to pass through the negatively charged surface of the SDS
micelle and into the hydrophobic interior. It is likely that the cleavage site is located inside the
hydrophobic core of the micelle.

TrpΔLE/VSD Fusion
Protein ~29kDa

Suspected cleaved VSD
~15kDa

Figure 22: SDS-PAGE analysis of Ni2+-cleavage of TrpΔLE-VSD fusion protein. To the left from the marker, we
see the fusion protein band (29 kDa) from the reaction precipitate and the next lane shows the same protein
which was still in solution after the reaction. There appears to be a faint band at the correct size for the cleaved
𝐍𝐚𝐯 𝟏. 𝟕 -VSD II product (15kDa). However, the reaction appears to be inefficient.

Additionally, we attempted to see the Ni2+ catalyzed cleaved product by MALDI mass
spectrometry (Figure 23). We were only able to see a peak that corresponds to the fusion
protein. It was uncertain at this point if the faint band on the SDS-PAGE in fact corresponds to
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the cleaved product. It is possible that the cleaved VSD product is not detectable by MALDI MS
under the conditions of analysis. Therefore, the best possible case given the results is that the
reaction is largely inefficient.

28.8kDa

Figure 23: MALDI mass spectrum of the 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II/Trp-Delta-Leader fusion protein after incubation with
2mM 𝐍𝐢𝟐+ for 16 hours. The mass of the fusion protein is 28.80 kDa. We therefore conclude that the reaction
was unsuccessful.

It was speculated that, if the Ni2+ ion was unable to enter the detergent micelle, the
reaction has a better chance of working in an organic solvent of some type, if the Ni2+ is still
able to dissolve. It was at this point that a solvent screen was performed in attempt to optimize
reaction conditions. The fusion protein was insoluble in 6 M guanidium without the presence
of any detergent, so that choice was abandoned. We had tested the reaction in solvents and
solvent mixtures in which we found that the fusion protein and the 2 mM Ni2+ were both able
to dissolve. SDS PAGE (Figure 24Figure 24) and MALDI MS had then confirmed that none of
the reaction conditions attempted resulted in cleavage of the VSD from the fusion protein.
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Chloroform/MeoH Postclv

25% TFE Postclv

30% CAN/10% MeOH Postclv

50% ACN Postclv

50% TFE Postclv

100% ACN Postclv

Chloroform/MeoH Preclv

25% TFE Preclv

30% CAN/10% MeOH Preclv

15kDa

50% ACN Preclv

20kDa

50% TFE Preclv

25kDa

100% ACN Preclv

37kDa

10kDa

Figure 24: SDS-PAGE of 𝐍𝐢𝟐+ cleavage of fusion protein in various solvents. From the first band to the right of
the marker are the pre-reaction samples (in order): 100% acetonitrile (ACN), 50% triflouroethanol (TFE), 50%
ACN, 30% ACN 10% MeOH, 25% TFE, chloroform/MeOH 𝟏: 𝟏 Following are the same samples in order after
incubation with 𝐍𝐢𝟐+ . We do not see the cleaved product band in any of the samples. The cleaved VSD should be
present at ~15kDa. While there is a band in that region, it is there in both precleave and postcleaved samples,
indicating that it is an impurity. We do not see any bands which correspond to the fusion protein or the cleaved
product, we suppose they may not be stable in the solvents used.

Being that the Ni2+ -catalyzed peptide cleavage appeared to be incompatible with our
particular system, the hydroxylamine peptide cleavage method was attempted to obtain the
Nav 1.7 VSD product from the fusion protein. The construct was made in the same way as the
nickel cleavage site vector, except with an N-G-N-G added to the sequence in between the
TrpΔLE and the Nav 1.7 VSD instead of the nickel cleavage site. A double cleavage site was
added instead of a single to help ensure proper cleavage. Hydroxylamine is known to cleave
peptides in between asparagine and glycine at alkaline pH47 (Figure 25). Being that neither the
TrpΔLE segment nor the VSD contain an N-G in the sequence, this is considered to be an
acceptable approach.
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Figure 25: Mechanism of hydroxylamine cleavage of NG dipeptide. A ring forms between when the asparagine
amide nitrogen of the side chain attacks the carbonyl carbon of the neighboring glycine residue. This is the factor
that contributes to the slow kinetics of this reaction. The amide nitrogen of the asparagine must be in the lone pair
bearing resonance state in order for this nucleophilic attack to occur which initiates the reaction.

The hydroxylamine cleavage was first attempted using SDS as the detergent to solubilize
the fusion protein. Upon addition of hydroxylamine, a precipitate started to become visible and
the amount was increasing over time. SDS-PAGE and MALDI told us that the reaction did not
work and that there was no protein in the precipitate. We believe that the hydroxylamine may
have reacted with the SDS to form an insoluble sulfonamide. The reaction was then attempted
again using n-lauryl sarcosine instead of SDS. The cleavage of the fusion protein was successful
in n-lauryl sarcosine, as confirmed by MALDI mass spectrometry (Figure 26). Having obtained
the cleaved VSD product, the next necessary step is the refolding of the VSD by exchanging
from denaturing detergent to a, zwitterionic phospholipid such as DMPC. Using this method,
the cleaved VSD remains in solution and can then be used for refolding.
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Figure 26: MALDI mass spectra of the fusion protein before incubation with hydroxylamine (top). The expected
mass of the fusion protein is 28.8 kDa. The product after overnight incubation with 1.1M hydroxylamine is
expected to be 15.05 kDa. The MALDI MS spectrum below shows the product after the reaction at the correct
size.
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It was observed by SDS-PAGE that some residual fusion protein remained in the
reaction solution after a week of cleavage. To improve the yield of the VSD, the reaction was
performed for two weeks and analyzed by SDS-PAGE. However, the amount of residual fusion
protein is roughly the same as when the reaction is performed for one week. Therefore, in the
remaining studies, the reaction was incubated for one week or less. It was observed that four
days incubation of the fusion protein with hydroxylamine gives roughly the same yield as for
one week. Therefore, we perform all further hydroxylamine cleavage reactions in this study
between four and seven days. To remove the unreacted fusion protein, size exclusion
chromatography (SEC) is performed. As can be seen in Figure 27, we have been able to
separate the unreacted fusion protein from the cleaved VSD and TrpΔLE fragments by SEC.
The TrpΔLE fragment elutes from the SEC column in the same peak as does the VSD in this
purification. However, it turns out that this is not a major concern being that the TrpΔLE
fragment precipitates out in the refolding step, which is performed after the SEC using DMPC,
as described in the following section. As can be seen in the figure below, the residual fusion
protein after cleavage is substantially less than the amount of the cleaved products. A yield of
roughly 3.5 mg/liter of medium is obtained after the SEC step. This is comprised of both the
VSD and the TrpΔLE. After the refolding procedure described in the following section, a yield
of roughly 2 mg of pure VSD per liter is obtained. As can be seen in the figure below, we have
been able to separate the unreacted fusion protein from the cleaved VSD and TrpΔLE
fragments by SEC performed in 1% SDS. The TrpΔLE fragment elutes from the SEC column in
the same peak as does the VSD in this purification.
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1
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25kDa
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Nav1.7 VSD
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TrpΔLE

Figure 27: SDS PAGE of SEC fractions of the 1.7 VSD cleavage products done in 1%SDS. Lanes 1-4 contain
unreacted fusion protein. Lanes 5-9 contain the VSD (upper band) and TrpΔLE (lower band), which both come out
in the same peak on SEC. This is not a problem, however because once the VSD is exchanged into DMPC, the
TrpΔLE precipitates out. The SEC chromatogram is shown above with the respect peaks corresponding to the
SDS-PAGE samples labeled, respectively.
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Refolding of 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II: Results
DMPC was added to the cleaved VSD as described in the refolding procedures section.
Being that DMPC is insoluble in water unless other detergent(s) are present, precipitated
vesicles of DMPC were expected. However, after roughly two weeks the solution continued to
remain clear. It is suspected that we have created soluble aggregates of DMPC which are
solubilized by residual SDS that is difficult to remove by dialysis. 1H NMR was performed on the
solution to assess the relative amounts of DMPC and SDS in the suspected composite
aggregates of DMPC (/Figure 29). DMPC shows a signature choline quaternary amine methyl
proton signal at roughly 3.3 ppm. Additionally, the β protons of SDS (with respect to the
sulfonate group) show a signal at 3.7 ppm. It could not be distinguished which of the peaks in
the 3.7-3.8 ppm region is due to the SDS β-sulfonyl proton because of crowding in that region.
However, upon integration of this entire region and comparison to the integration of the 3.35
ppm peak from the quaternary amine methyl protons of DMPC, the relative amounts are
roughly 50:1 (DMPC proton: SDS proton). There are nine DMPC protons contributing to the
peak at 3.35 ppm, while there are two SDS β-sulfonyl protons. This normalizes to just over
10:1 DMPC:SDS. However, this is an upper limit for the amount of SDS present since the
entire 3.7-3.8 ppm region was integrated over and only one of those peaks will actually be due
to the SDS. A different explanation for the fact that vesicles do not precipitate could be that
the dialysis conditions favor the formation of small unilamellar vesicles that do not aggregate
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into larger particles and are therefore resistant to pelleting in an ultracentrifuge. The size range
for these particles determined by dynamic light scattering (see below) is also consistent with

Intensity

this second explanation.

1H ppm
Figure 28: 1-H NMR spectrum of the solution containing the isolated 𝐍𝐚𝐯 𝟏. 𝟕 VSD in DMPC/SDS after
Figure 29: Close view of the proton NMR spectrum of the DMPC/SDS solution
as in the previous figure.
dialysis. We suspect the amount of DMPC is significantly higher than any remaining SDS, due to the
molecular assembly could be too large for feasable solution state NMR s
relative intensity of the choline methyl proton signal (3.35 ppm here) relative to any peaks that could be
due to SDS. We suspect that the size of the molecular assembly is large (i.e., non-isotropic) due to the
broadness of the alkyl chain proton peak at ~1 ppm.
udies.

As can be seen in figure 25, the 1H NMR peaks from the alkyl region of the detergents
are broadened. This could indicate that the soluble aggregate system that we have made is too
large for feasible solution state NMR studies. In consideration of the refolding of the VSD we
wanted to asses the secondary structure of the isolated VSD which we belive is embedded into
the DMPC lipid aggregates. The reason we conclude this is that the solution is transparent with
no precipitate. After centrifugation and filtration with 0.2 μm filter, the VSD is still in the
solution as verified by MALDI MS and UV-VIS spectroscopy, indicating that it is soluble in the
56

DMPC aggrgegates. To investigate the size of the protein/DMPC aggregates quantitatively, we
performed dynamic light scattering (DLS)49. DLS is able to extract the diffusion coeficient of a
sample in solution based on the change in scattered light with the incident beam and detector in
a fixed position from one point in time to another. The motion of the particles in solution is
assumed to be a random process and therefore the correalation function is taken to follow that
of a brownian system. The equations below show the autocorrelation function, g the

𝑔(𝑞; 𝜏) = 𝑒 −𝑞

2𝐷

𝐷=

𝑘𝐵 𝑇
6𝜋𝜂𝑟

diffusion coefficient, D. The q variable in the autocorrealtion function is the length of the
scattering vector, which can be determined from knowing the scattering angle and the
wavelength of the scattered light. The diffusion coeffient in the above equation is derived from
the Einstein-Stokes equation. In the Einstein-Stokes equation, 𝑇 is the temperature, 𝑘𝐵 is
Boltzmann’s constant, 𝜂 is viscosity and 𝑟 is the radius of the (assumed to be spherical) particles
in solution49. DLS was performed on the Nav 1.7 VSD in DMPC solution and can be seen in
Figure 30. The average diameter of the particles is 80nm, which indiactes that they are large
aggregates of lipids with VSD embeded. As explained above, these aggregates could be either
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disc-like aggregates of DMPC bilayer with some residual SDS (like very large bicelles) or small,
stable unilamellar vesicles.

Figure 30: DLS of 𝐍𝐚𝐯 𝟏. 𝟕 VSD in DMPC solution, prepared as described. The average radius of the particles is
80nm, which indicates large lipid aggregates. It is assumed that the particles have spherical geometry in the
calcultion of size. However, this is assumed to be a reasonable assumption being that the particles are tumbling in
solution.

In order to asses the state of the secondary structure, we performed circular dichroism
(CD) spectroscopy on the detergent/protein containing solution . The CD spectrum tells us
that the protein is in the α-helical state, which is the case for all known sodium channels50
(Figure 31). Therefore, the secondary structure is in the same state we expect it to be in native
conditions. Depending on the results, we will attempt to make bicelles by adding the short
chain detergent DHPC, or move directly into isotopic lableing and protein NMR studies
beginning with HSQC (heteronuclear single quntum coherence). See figure 36 located in the
following section for results of DLS with the VSD in bicelles. However, before moving on to
exchanging the protein into alternate types of lipid systems which are suitable for NMR studies,
it is vital to obtain evidence that our VSD in the DMPC system posseses a native-like tertiary
structure.
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Figure 31: CD spectrum of the 𝐍𝐚𝐯 𝟏. 𝟕 VSD in the DMPC/SDS system that we have made. The spectrum
resembles that of an α-helical protein. We conclude that the secondary structure of our recombinant VSD is in the
state that we expect it to be in native conditions.

Beyond Secondary Structure: Binding Studies to Validate Proper
Folding of the VSD
In order to validate that the Nav 1.7 VSD that has been produced using this procedure
adopts a native-like conformation, we have conducted binding studies on the VSD with
protoxin II. ProTxII in this case was produced recombinantly and purified using a procedure
from Blumenthal et al15. The fraction containing purified ProTxII was analyzed by MALDI MS as
can be seen in figure 32. The quantitative binding experiment that was performed in this study
was microscale thermophoresis (MST). MST has been extensively used in recent times as a tool
to understand binding in biochemical systems. The technique utilizes the fact that florescence
intensity of a fluorophore has a specific and sensitive signature across an applied thermal
gradient. Signature here refers to the dependence of fluorescence intensity on temperature.
Slight changes in the system (i.e., binding) will change this signature, and the more binding the
more it will change until reaching saturation. This signature is fundamentally based on the
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translational diffusion of the fluorescent molecules increasing with increased temperature.
Larger complexes will diffuse more slowly, therefore the binding can be detected in this way.
This allows us to calculate the K 𝑑 by fitting the data to a binding isotherm51. Optimization of the
MST conditions proved that the optimal way to perform the experiment with our Nav 1.7 VSD
and ProTxII was to fluorescently tag the toxin and titrate in the VSD. The resulting data was fit
to a binding curve as can be seen in Figure 33. The K 𝑑 obtained from the fit was averaged
between two MST runs for a value of 130 nM. Values for IC50 of ProTxII for Nav 1.7 found in the
literature have been typically in the 2-10 nM range24. However, we do not expect that our K 𝑑
using this system be comparable to the literature for several reasons. The first reason is that
we are working with an isolated VSD, while the electrophysiology studies done in the literature
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using ProTxII were done with the entire
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Figure 32: MALDI mass spectrum of ProTxII, as isolated from reverse-phase HPLC. The mass of the +1 peak is
3.89kDa, as expected.

Nav 1.7 channel. Additionally, the electrophysiology studies are done using whole cell methods,
while we are working with a model membrane lipid system with DMPC. Therefore, we have
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reason to suspect that the recombinant Nav 1.7 VSD is adopting at least some of its native tertiary
structural characteristics in the system we have designed. In order to be certain that the binding
data we have obtained in this study was truly due to ProTxII binding to the VSD and not the
DMPC, we performed a control titration with only DMPC and ProTxII. The same amount of
DMPC was titrated into the ProTxII solution as was used when the VSD was present. The MST
results for this (Figure 34) showed that there is much weaker interaction with the vesicles alone.
The binding curve failed to reach saturation, and the analysis software was unable to provide a
reliable K 𝑑 fit. The given K 𝑑 for this system (although unreliable) is 14 μM. Even considering that
the binding fit had some degree of accuracy, this K 𝑑 is 2 orders of magnitude higher than that of
the experiment done with the VSD. These results tell us that the ProTxII is not binding strongly
to the lipids, it is binding strongly to the VSD. The binding results here support the hypothesis
that the VSD produced using this methodology is exhibiting a native-like conformation in the
DMPC aggregates.
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Figure 33: MST traces (above) and binding curve (below) for ProTxII/𝐍𝐚𝐯 𝟏. 𝟕 VSD in the DMPC system. The
average 𝐊 𝒅 from two experiments is 130 nM.

It must be noted that the 14 μM K 𝑑 calculated for the DMPC titrated into ProTxII
solution may not be entirely accurate, since the binding curve does not fully saturate through the
course of the titration in this MST experiment. However, in any case the toxin binding to DMPC
alone is significantly weaker than it is for VSD/DMPC. The true K 𝑑 could in fact, be higher than
14 μM since the binding curve does not fully saturate and the fit is therefore poor.
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Figure 34: MST traces (above) and binding curve (below) for ProTxII with DMPC titrated in without
𝐍𝐚𝐯 𝟏. 𝟕 VSD. 𝐊 𝒅 calculated is 14 μM, which is two orders of magnitude higher than that of when the VSD is
present.

𝐍𝐚𝐯 𝟏. 𝟕 VSD in Bicelles and Micelles Results:
The molecular assembly of the Nav 1.7 VSD in DMPC is most likely too large to obtain
useful information by solution state NMR, as can be seen by the 1H NMR data in . In order to
make the system smaller for such studies, we first aimed to create bicelles with our VSD
contained within them. Bicelles are small disks of lipid bilayer which are analogous to vesicles, but
without a continuous manifold forming a complete sphere of bilayer. This continuity is broken by
the addition of short chain lipids to the long chain lipids in a certain molar ratio. In practice, this
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is typically achieved by using a long chain lipid such as DMPC and a short chain lipid such as DHPC
in molar ratio ranging from 0.5-0.8 for isotropic bicelles52. The molar ratio of DMPC:DHPC is
used so often in membrane protein biophysics that the value has been designed with a name, the
“q-value”. Lower q-value corresponds to smaller bicelle size, as shown in Figure 35.

Figure 35: Schematic representation of bicelles at different q-values. Lower q-values will result in smaller bicelles.

In this study, we first produced Nav 1.7 VSD in bicelles with q= 0.5. We did so by adding
the necessary amount of DHPC directly to the solution containing the VSD in DMPC which is
solubilized by residual SDS. The resulting solution was analyzed via 1H NMR and DLS. As can be
seen in Figure 36, the size of the assembly significantly decreased from roughly 80 nm in the
DMPC system to 5 nm upon adding DHPC. Next, we had produced 15N labeled VSD using the
same method as before, up to the point of incorporation of the VSD into bicelles for an HSQCTROSY NMR experiment. Unfortunately, it was at this point that we noticed the VSD is likely
not very stable in bicelles. It was discovered that the Nav 1.7 VSD-II in DMPC/DHPC bicelles
precipitates out of solution within 1-2 hours after preparation at room temperature. Increased
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temperature will increase the rate of precipitation. Therefore, NMR experiments for structural
analysis would be unfeasible. Potential resolution of this problem could be to change the q-value
or the protein:lipid ratio. An experiment was done in which we had prepared 16 samples of
Nav 1.7 VSD, each in bicelles with varying q-value and protein:lipid ratio. Unfortunately, there
were negligible differences in the stability between each of the samples. This was seen by visually
inspecting for precipitation after incubation at 37˚C along with SDS gel confirmation.

Figure 36: Dynamic light scattering (DLS) measurements of the 𝐍𝐚𝐯 𝟏. 𝟕 VSD in DMPC/DHPC bicelles. Results
indicate that the size of the bicelle assembly is significantly decreased in the DMPC/DHPC assembly as compared
to the DMPC system.

Bicelles comprised of DHPC/DMPC appear to be an unideal system for the folded
Nav 1.7 VSD to retain native-like conformation and remain in solution for solution state NMR

experiments. Therefore, if we are to do such experiments it would be necessary to use an
alternative membrane mimetic system. Bicelles are generally thought of as a superior membrane
mimetic than micelles due to their bilayer-like fold. However, micelles could potentially offer a
viable alternative for such a system. Micelles are also, in general, more stable than are bicelles 53.
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In this study, we had prepared the Nav 1.7 VSD in DMPC as before, and instead of adding DHPC
to make bicelles, we extract the VSD from the DMPC using a high concentration of detergent.
This is followed by dialysis against low concentration of that same detergent to remove excess
DMPC. We had attempted this experiment with several different detergents which are commonly
used as membrane mimetics and found that the one which works best for extracting the VSD is
1-Myristoyl-2-Hydroxy-sn-Glycero-3-Phosphocholine (LMPC). The VSD is exchanged from the
DMPC system by extracting with LMPC. 1H and

31

P NMR were used to assess the

relative detergent composition and size of the system, results are shown in figure 37 and figure
38, respectively. These results indicate that the size of the system is decreasing upon
exchanging into LMPC, which can be seen from a decrease in the NMR peak-width for both the
alkyl chain protons and the lipid/detergent phosphorus.
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Figure 37: Comparison of the 1H NMR spectra of 𝐍𝐚𝐯 𝟏. 𝟕 VSD in the DMPC system (left) and in the LMPC
system (right). Broadness of the alkyl chain peaks around 1 ppm is decreased in the LMPC system, indicating that
the LMPC system is smaller.
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Figure 38: 31P NMR spectra of 𝐍𝐚𝐯 𝟏. 𝟕 VSD in DMPC (right) and in LMPC (left). The left peak in the LMPC
spectrum corresponds to DMPC. This indicates that there is some DMPC remaining in the system, however the
LMPC peak is significantly larger so the system is largely comprised of LMPC.
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We have been able to prepare a sample of pure Nav 1.7 VSD in LMPC at 300 μM
concentration and 1mL volume, an amount that is more than what is typically considered
suitable for solution state protein-NMR. There appears to be no loss of VSD due to
precipitation for at least two weeks after preparation, while storing at 4˚C, as was seen by
visual inspection and SDS gel confirmation.

Nav 1.7 VSD
TrpΔLE

Figure 39: SDS PAGE of Na v 1.7 VSD after hydroxylamine cleavage. The top band of the right two lanes is the
VSD (15 kDa). The lower band is the TrpΔLE (≈13 kDa) while sample is in a 1% SDS solution. The left lane shows
the VSD after exchange into DMPC and subsequent dialysis against water. The TrpΔLE band gradually disappears
the longer the dialysis is done against water, as the TrpΔLE is insoluble in water. The samples here are dilute(≈50
µM), but they are concentrated before NMR studies. SDS PAGE of the concentrated sample is not as visually
pleasing, due to the streaking of the lanes from the high lipid concentration.
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VGSCs: Structural and Functional Relations to ToxinBinding and Dynamics
VGSCs: A Historical Background

The modern understanding of action potential began with a study done in 1952
by Hodgkin and Huxley54. In their work, a quantitative description of the depolarization of the
cell membrane corresponding to a sodium influx was formulated. This description was also
carried out for the entire process of the action potential. This work made it clear that the
action potential is initiated by and inward sodium current and that the electrical response is
terminated by the outward movement of potassium ions. Hodgkin and Huxley’s work is still
regarded as one of the most important studies ever conducted in the field of physiology. The
1952 paper, A Quantitative Description Of Membrane Current And It's Application To Conduction And
Excitation In The Nerve is considered the birth of modern physiology. Shortly after this
publication, there was much attention on the mechanism responsible for membrane conduction
itself. The work of Hille, Armstrong and Mullins in the 1960s made apparent that there are two
channels in the excitable cell membrane. In a paper by Mullins in 1968, it is concluded that one
of the channels is responsible for the inward sodium current, while the other is what causes the
outward potassium current55. The first indication of a sodium channel selectivity filter along
with a detailed kinetic model of the channel’s transition between states was found by Hille in
197556. In all, these early studies are the foundation of what we know today about action
potential and voltage gated ion channels. The amount of detailed information that was able to
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be extracted by electrophysiological experiments and mathematical modelling is remarkable. By
the early 2000s, it was known that the human VGSCs have a functional α-subunit composed of
four different repeating units (hetero-tetramers) of six transmembrane helices, along with
modulatory β subunits. The genes and localization of expression of VGSCs had also been
known at that time57. The 10 major isoforms of human VGSCs and their localization in the body
are shown in Figure 40. The genes were named SCN1A-SCN11A for the VGSC isoforms. It was
known that Nav 1.7 is expressed largely in the peripheral nervous system by 2000, and the study
by Nasser, et. al. in 2004 put Nav 1.7 in the stage light as it was shown to be crucially involved
with pain response2.

Figure 40: 10 major human VGSC isoforms and where they are largely expressed in the body57.

One can argue that the largest breakthroughs in sodium channel research occurred in
stages. The early stage of Hodgkin and Huxley through Hille and Mullin initiated the field itself.
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In the late 1990s and early 2000s, the sequences and expression profiles were worked out for
all the human VGSC isoforms. This research was accompanied by a plethora of
electrophysiology studies which illuminated the functional mechanisms and models of
conformational switches of VGSCs.
The latest breakthrough stage for VGSC research began in 2011 and continues to the
present day. In 2011, the first atomic resolution structure of a VGSC was reported58. The
crystal structure of the bacterial VGSC called Nav Ab had been solved by Payandeh working in
the group of William Catterall. The structure of Nav Ab not only illuminated structural
elements of the VSD that are likely to be involved with gating modification, but also revealed
the molecular details of the ion pore selectivity filter. In this study, the VSD was reported to be
in the activated state, due to the orientation of positively charged arginine residues in the S4
segment. It was already established that positively charged residues of the S4 helix are what
causes the initial conformational switch as the cell membrane becomes depolarized during an
action potential. During the action potential, the inside of the cell becomes more positive and
the positively charged residues (such as arginine) will move outward towards the outside of the
cell as a result. This event results in the outward movement of the S4 helix, which initiates the
conformational switch of the pore from the closed to the open state23. It is for these reasons
that the S4 segment is referred to as the voltage sensor. This model which states that the
movement of the S4 helix is what initiates the opening of the sodium channel had been worked
out almost completely due to electrophysiological studies and homology modelling. With the
reported crystal structure of Nav Ab , the voltage sensor can finally be visualized rather than
speculated. Specific salt-bridge interactions occur between the arginine residues of S4 and the
negatively charged residues of the S1-S2 helices, stabilizing the high density of positive charge. In
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Nav Ab , the distinct regions of negatively charged residues of the S1-S2 helices are classified as:
intracellular negative charge (INC), and extracellular negative charge (ENC) regions 58. The
conformational movement of the S4 helix during depolarization of the membrane potential is
facilitated by the continual rearrangement of salt-bridge interactions between S4 arginine
residues and the negatively charged residues of the INC and ENC (Figure 41). This is what is
thought to provide a low-energy path for the S4 movement which initiates the conformational
switch that leads to channel opening 58.

Figure 41: Side view of the crystal structure of the 𝐍𝐚𝐯 𝐀𝐛 VSD. R1-R4 are the four arginine residues of the S4
helix which give it the voltage sensing capabilities. The salt-bridge interactions between the arginine residues and
the negatively charged residues of the ENC and INC can be seen58.
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In addition to providing insight into the molecular details of the VSD which are behind
the conformational transitions during channel activation, the structure of the pore of Nav Ab
proved invaluable in understanding the molecular mechanisms of Na+ ion selectivity (Figure 42).
It is seen that a Na+ is in partially hydrated form when it goes through the selectivity filter of
Nav Ab . The structure indicates that the Na+ is surrounded by four water molecules which
interact which backbone carbonyls such as those from Thr175 and Leu176. The Na+ ion
appears to directly interact with the carbonyl of the side chain of Glu177, which is thought to
be crucial for ion selectivity58.

Figure 42: Selectivity filter of 𝐍𝐚𝐯 𝐀𝐛 in the crystal structure. Hydrated Na+ ions are shown as red with blue
spheres in the extracellular region. Key residues for ion selectivity are labeled, the backbone carbonyls being
indicted with an asterisk58.

Interestingly, the selectivity filter of Nav Ab is significantly larger than that of the
bacterial potassium channel, KcsA. KcsA was the earliest ion channel of which the atomic
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resolution structure has been solved59. The structural comparison reveals that, while potassium
channels permeate K + ions which are not hydrated, sodium channel selectivity filters allow the
passage of Na+ in complex with four water molecules. Shortly following the published structure
of Nav Ab , another crystal structure of a bacterial VGSC was reported. The structure of the
NaChBac orthologue Nav Rh by x-ray crystallography was reported in 2012 by Zhang, et. al.19.
Unlike the crystal structure of Nav Ab , that of Nav Rh was found to be in the closed
conformation. That is, the pore of Nav Rh is closed to Na+ ions in the state in which the
channel was crystallized in. The Nav Rh VGSC is an asymmetric tetramer, unlike Nav Ab . While
Nav Rh is a homotetramer, like all known bacterial VGSCs, the four repeating units of VSDs
and PDs (S1-S6 helices) do not have a fourfold symmetry along the central pore axis (Figure
43). This feature is thought to make Nav Rh a superior model for mammalian channels
compared to other bacterial VGSCs, being that mammalian channels are asymmetric pseudotetramers. The crystal structure of the Nav Rh VSDs are seen to be in the depolarized
conformation.

Figure 43: Crystal structure of Nav Rh with view from the cytoplasmic side. Unlike other known bacterial
VGSCs, Nav Rh does not have a fourfold axis of symmetry about the central pore axis.
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That is, the VSD conformation exhibited by the Nav Rh VSDs in the crystal structure is the
same as that of the channel once the transmembrane potential has depolarized as a result of
action potential, and before the membrane repolarizes. The S4 helix in the depolarized state is
positioned upwards towards the extracellular leaflet of the phospholipid bilayer. As in Nav Ab ,
there are negatively charged residues of Nav Rh which stabilize the positively charged arginine
residues of the voltage sensor. In particular, the residues Asp48 and Glu58 of the S2 helix form
ion pairs with arginine residues of S419.
The ion pairs between the arginine residues of S4 and nearby negatively charged
residues are believed to occur in virtually all voltage gated sodium and potassium channels.

Figure 44: Alignment of the four VSDs of Na v Rh in the crystal structure. Arginine residues of the S4 helix are
labeled as well as E58, which is thought to form ion pairs with the arginine residues which fluctuate during
conformational change19.

The collection of these charges have been termed gating charges9. This term is fitting,
being that the disruption of these ion pair interactions as a result of membrane depolarization
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are what leads to the conformational switch of the channel from the closed to the open state.
A current model which describes the movement of the S4 helix during depolarization is called
the sliding-helix model. This sliding-helix model states that the center region of the S4 helix
undergoes a conformational change from an α-helix to a 310 helix. This movement results in an
exchange of some of the ion pairs between arginine residues and anionic residues. The slidinghelix model is currently one of the most accepted models in describing the motion of S4 during
cell membrane depolarization9.
Cryo-electron microscopy has lately been responsible for the structural elucidation of a
variety of protein complexes which could be very difficult or impossible to achieve by x-ray
crystallography or NMR. The technique of cryo-EM relies on the freezing of a protein sample
onto a grid and then uses special focusing/defocusing methods and Fourier optics to
reconstruct images from the electron beam scattering from the sample. Being that the protein
sample does not need to be crystallized, the images obtained in a cryo-EM experiment will
contain multiple protein molecules in slightly different conformational states, reflecting the
dynamical motion of the proteins at the moment of freezing. Additionally, the images will
contain proteins in different orientations. Software programs have been developed to analyze
and reconstruct the atomic resolution structure of proteins from these different images in a
method which is known as single particle reconstruction60. The recent outbreak of cryo-EM
protein structures has been dubbed the cryo-EM revolution. This revolution has fostered the
first atomic resolution structures of human VGSCs, beginning with Nav 1.4. The structure of
human Nav 1.4 was determined by cryo-EM at 3.2 Angstrom resolution in 201861. This
monumental structure clearly illustrates the asymmetry of the mammalian sodium channels. The
asymmetric selectivity filter was resolved clearly, with a local resolution of 2.8 Angstroms near
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the DEKA motif. DEKA stands for Asp-Glu-Lys-Ala residues which are crucial in mammalian
VGSC selectivity filters. Each of the residues comes from a different one of the four repeat Ploops. The P-loops are the loops which are located between S5 and S6 helices of the pore
domains. The DEKA motif provides a path in the pore region which allows the entrance of
hydrated Na+ , but not other ions like K + 62. The structure of Nav 1.4 also provided the first
visualization of the inactivation gate, another unique feature of mammalian channels that is not
present in the bacterial channels. The process of fast inactivation is crucial for mammalian
excitable cell repolarization shortly following action potential. This process must be timed with
precision for neuronal and/or muscular signals to be sent and processed by the central nervous
system in the millisecond timescale. The molecular mechanism behind the process of fast
inactivation has been found to involve an intracellular loop between repeats III and IV of
VGSCs. A triad of hydrophobic residues forms a motif on this loop which can block the sodium
channel pore from the intracellular side which is how fast inactivation occurs. This hydrophobic
triad is comprised of an isoleucine, phenylalanine and a methionine residue and is therefore
known as the IFM motif11 (Figure 45).

Figure 45: Cartoon representation of the cryo-EM structure of 𝐍𝐚𝐯 𝟏. 𝟒focused on the region between repeats III
and IV. The Inactivation gate is shown in gold, with the IFM motif near the end of the linker 61.
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Roughly one year following the release of the Nav 1.4 structure, the cryo-EM structures
of human Nav 1.7 in complexes with two different toxins was published3. The Nav 1.7 was in
complex with ProTxII in one structure (Figure 46), while in complex with HWTXIV in the
other. The structures were determined with an overall resolution of 3.2 Angstroms. Each of
the toxin bound structures required the addition of a pore blocking compound for structural
determination in this case. Nav 1.7 in complex with ProTxII was treated with Tetrodotoxin
(TTX), while the channel in complex with HWTXIV required the addition of Saxitoxin (STX).

Figure 46: Cryo-EM structure of 𝐍𝐚𝐯 𝟏. 𝟕 in complex with β2 along with ProTxII. ProTxII is bound to both VSD II
and IV3.

TTX and STX are both potent non-peptide pore blocking toxins which occur in nature63. The
reported structure of Nav 1.7 is also in complex with the modulatory subunits β1 and β2. While
the core of the channel was resolved with high resolution, the peripheral regions of the channel
were poorly resolved (roughly 5 Angstroms), which prevented accurate docking of the toxin
structures3. The pore of Nav 1.7 in the reported structure is said to be in the closed state. This
is no surprise, being that the channel was treated with large amounts of pore-blocking toxins
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prior to cryo-EM studies. Although ProTxII and HWTXIV are seen to bind to the same region
of VSD II, there are conformational differences in the channel between the two toxins (Figure
47). The S4 helix is present as a 310 helix in both Nav 1.7 /ProTxII and Nav 1.7 /HWTXIV.
However, the arginine residues of S4 (R2-R4) are positioned more towards the extracellular
side than those of Nav 1.7/HWTXIV. Additionally, the binding modes of ProTxII are quite
different between VSD II and VSD IV3. While residues from the S3-S4 linker appear to be
involved in the binding of ProTxII to both VSD II and IV, the orientation of ProTxII is quite
different for the two different VSDs. Although the binding is not resolved to the atomic level,
these results shed light on the general framework of the binding between these two gatingmodifier toxins and Nav 1.7 .

Figure 47: Illustration of the two different binding modes of ProTxII for𝐍𝐚𝐯 𝟏. 𝟕. The toxin shown in purple
represents the binding to VSD IV, while the orange is ProTxII when bound to VSD II3.

𝐍𝐚𝐯 𝟏. 𝟕 VSD Binding Studies with GpTxI Procedures:
GpTxI toxin was synthesized using FMOC (florenyl methyloxy carbonyl chloride) protection
group-based peptide synthesis. Coupling reactions were performed using an Applied
Biosystems™ ABI 433A peptide synthesizer. Amide (MBHA) resin was used to couple the first
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amino acid of the peptide. Activation of carboxyl groups was performed using 1hydroxybenzotriazole (HOBt) and n-methyl pyrrolidine (NMP) was used as the reaction
solvent. Deprotection of FMOC groups was performed using piperidine. After side chain
protection group cleavage and cleavage from the resin with triflouroacetic acid (TFA) containing
triethyl silane (TES), the crude peptide was precipitated using diethyl ether. The resulting crude
peptide was dissolved in water with 0.1% TFA and then purified via reverse-phase HPLC using a
0-100% acetonitrile gradient over 30 minutes (with a flow rate of 3 mL/min) using an Agilent ™
C18 semi-preparative HPLC column. Roughly 400 mg of the linear peptide toxin was obtained.
Roughly 10 mg of the purified toxin was then subjected to oxidative refolding in accordance
with a publication in which GpTxI was synthesized and refolded29. The HPLC-purified toxin
solution was diluted from roughly 15 mL to 4 L with refolding buffer. The refolding buffer
contains 3.3 L of HPLC-grade water, 300 mL of acetonitrile, 2.0 g of oxidized glutathione, 1.0 g
of reduced glutathione and 400 mL of Tris-HCl pH 7.5. The solution is stirred overnight at
room temperature. The refolded peptide is then concentrated by ion-exchange
chromatography (IEX) using a 5 mL SP (sulfonyl propyl) column purchased from GE ™ life
sciences. Prior to IEX, the pH of the peptide solution is lowered to 4.0 using glacial acetic acid.
The IEX was performed on an AKTA Pure ™ FPLC instrument using 20 mM NaOAc (sodium
acetate) pH 4.0 for buffer A and B and with 1 M NaCl in buffer B only. This yielded in ~7 mL of
refolded toxin which was then purified by reverse-phase HPLC in the same way as previously
described for the linear toxin. The HPLC-purified, refolded toxin solution was then lyophilized
and stored until use in analytical experiments. Prior to MST experiments, the refolded GpTxI
was labeled with Alexa Flour 400nm ™/NHS-linked dye and labeled toxin was purified from
unreacted free dye using a G25 desalting column. MST experiments were performed by
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titrating Nav 1.7 VSD-II in DMPC solution into 50 nM of labeled GpTxI. Each MST run was
performed using a 16-point titration on a Nano Temper ™ instrument as described in the
previous chapter.
The VSD point mutations F813A and D816A were introduced (separately) by quickchange mutagenesis PCR using the Agilent ™ quick-change kit. The Nav 1.7 VSD-II/TrpΔLE
plasmid construct in pSW02 with the hydroxylamine cleavage site was directly used as the
template DNA and primers were designed to introduce the single point mutations F813A and
D816A. After confirmation of the correct sequences, we used the two constructs (one with
the F813A VSD and another with D816A) to produce two mutant VSDs using the same
expression, purification and refolding procedure as for the wild type.

𝐍𝐚𝐯 𝟏. 𝟕 VSD Binding Studies with GpTxI Results:

Due to recent progress in the structural studies of Nav 1.7 with ProTxII3 64, we are
particularly interested in knowing how Nav 1.7 VSD binds to GpTxI. GpTxI is a spider toxin that
has been shown to directly inhibit pain in mice. We aim to investigate differences in
Nav 1.7 binding to ProTxII and GpTxI. In this study, we have used FMOC peptide synthesis to
prepare GpTxI, and oxidative refolding was performed using a published method 29. The
refolding of GpTxI was confirmed by ESI MS and HPLC. To further validate the folded state
adopted by the VSD produced by this methodology, we have performed an MST binding study
of the VSD with the refolded GpTxI. Additionally, being that IC50 values of both ProTxII and
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GpTxI are known with Nav 1.7 , it would be interesting to see if the relative values of K 𝑑 are
comparable to the relative values of IC50 for these two toxins. MST was performed by labeling
the GpTxI with AlexaFlour ™ 488/NHS dye. The Nav 1.7 VSD was titrated into samples with
25 nM GpTxI, using the blank DMPC solution described above as the solvent throughout the
experiment. The binding curves were fit to the results using the NanoTemper ™ analysis
program (Figure 48).
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𝐍𝐚𝐯 𝟏. 𝟕 VSD Binding to GpTxI
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Figure 48: MST binding curve generated for Nav1.7 VSD in DMPC solution titrated into 25 nM of
fluorescently labeled GpTxI. The 𝐊 𝒅 was calculated to be 360 nM.

The K 𝑑 for GpTxI binding to the VSD in this experiment is 360 nM. This is roughly 3X
that of which was found for ProTxII (130 nM). This comparison is quite interestingly very
similar in trend to the activity differences between these two toxins. The IC50 of ProTxII for
Nav 1.7 is around 3 nM, while that for GpTxI is 10 nM29. While the determining factors behind
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an IC50 value are more complex than the determining factors of the K 𝑑 , the relative values of
the two quantities found for this system appear to be aligned. For instance, the IC50 will
necessarily not only depend on binding affinity, but on several other factors including the toxin’s
effect on channel inactivation. However, the ratio between IC50 values of ProTxII and GpTxI
inhibition of Nav 1.7 is almost the same as the relative K d values. Therefore, these results
indicate that the main determinant of the IC50 values for ProTxII and GpTxI toward Nav 1.7 is
the strength of binding. This relative binding study could be used to advance the understanding
of the mechanisms which determine channel inhibition by toxins when compared to the IC50
values as we have done here.
In addition to comparison of the K d values of Nav 1.7 for different toxins using this
system, we would like to understand more about the molecular mechanism behind the binding
itself, particularly for GpTxI. Besides doing NMR studies, we can deduce information regarding
the residues involved with binding by making point mutations and comparing the binding
profiles of the mutants to that of the wild type. There have been previous studies which
indicate that F813 of Nav 1.7 VSD-II is critically involved with ProTxII binding12. This was
established roughly 10 years ago via electrophysiology studies. Additionally, there have been
studies which support that D816 of the VSD is also very important for ProTxII binding64. These
residues are part of the FLAD sequence, which resides in the paddle motif of Nav 1.7 VSD-II.
However, no studies have yet determined such details regarding residues of the VSD which are
involved in the binding to GpTxI. Although the structures of GpTxI and ProTxII are quite
different, we suspect that residues of the VSD-II paddle motif are also involved with GpTxII
binding. Therefore, we investigate the interaction between GpTxI and Nav 1.7 VSD-II by making
the point mutations to F813A and D816A in the VSD and comparing the binding profiles with
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that of the wild type. The mutant VSDs were expressed, purified and refolded in the same way
as was done with the wild type. MST was then performed by titrating the resulting VSDs in the
DMPC solution against labeled GpTxI. As can be seen in Figure 49, the binding of GpTxI
towards the VSD is significantly affected by the F813A mutation. The K 𝑑 calculated between the
F813A mutant and GpTxI is roughly 2 μM, while that for the wild type is 360 nM. Therefore, it
appears from this study that F813 of Nav 1.7 VSD-II is either directly or indirectly involved with
GpTxI binding. Being that F813 is in the region of the paddle motif, which is known to bind to
other ICK toxins such as ProTxII, we believe that the mutation directly perturbs the
interaction.
The mechanism by which ProTxII finds the paddle motif of Nav 1.7 VSD-II is thought to
occur by the toxin binding to the membrane first, before reaching the channel. Based on the
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Figure 49: Binding curve fit obtained from the MST of the 𝐍𝐚𝐯 𝟏. 𝟕 VSD mutant F813A titrated into 25nM GpTxI.
The calculated 𝐊 𝒅 is roughly 2μM, which is an order of magnitude greater than the wild type VSD.
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structure of the Nav Ab/Nav 1.7 chimera published in 2019, the hypothesis of membrane
partitioning of ProTxII residues was validated. The chimera in this study contains the human
Nav 1.7 sequence only for VSD-II. As can be seen from the structure, hydrophobic residues of
ProTxII such as W5 and W24 partition into the interface between the VSD and membrane
lipids. F813 is located at this interface, and can be seen to be in contact with the hydrophobic
residues of ProTxII in the published structure64. We therefore suspect a similar mechanism to
take place with GpTxI binding to VSD-II. F813 appears to be an important factor in the
hydrophobic interactions taking place in Nav 1.7 /ICK toxin binding.

Figure 50: Crystal structure of ProTxII bound to the VSD of 𝐍𝐚𝐯 𝐑𝐡/𝐍𝐚𝐯 𝟏. 𝟕 chimera. The toxin partitions into
the VSD/membrane interface. F813 of the VSD can be seen to contact hydrophobic residues of the toxin such as
W5 and F8134.
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After identifying a residue in Nav 1.7 VSD-II that is important for GpTxI binding which is
likely based on a hydrophobic interaction, we next aim to find a stronger type of interaction
that could also be at play in this binding system. The hydrophobic interaction is believed to be
especially crucial for binding specificity, in the case of ProTxII binding with Nav 1.7 VSD-II64.
This agrees with the model which states the toxin will interact with the membrane first and
then find the VSD once bound to the hydrophobic membrane interior. Particularly, hydrophobic
residues of the ProTxII will first interact with the VSD at the membrane-S3/S4 helix interface. If
the binding is initiated in this region, it is not surprising that F813 is important for specificity.
Both GpTxI and ProTxII are selective for Nav 1.7 , and both have strong affinity. This strong
affinity could have contribution from electrostatic interactions that are also involved with toxin
binding. One residue of the VSD-II paddle motif which appears to make contacts with ProTxII
in the chimera structure is D816. D816 comes in close proximity to R22 of ProTxII, so it is
highly likely that an electrostatic interaction is taking place which is contributing to the strength
of the binding64. We therefore investigate whether the same residue is involved with binding
with GpTxI using the same methodology as was used to probe the F813 interaction. We
performed the D816A mutation on Nav 1.7 VSD-II followed by MST binding assay with GpTxI.
As can be seen in Figure 51, the D816A mutation has a significant impact on the binding of
GpTxI to the VSD. The calculated K 𝑑 for the D816A mutant is 6 μM, compared to 360 nM for
the wild type. Therefore, we suspect that D816 is involved with the binding of GpTxI to
Nav 1.7 VSD-II. It is highly likely that D816 forms an electrostatic contact with one or more
positively charged residues of GpTxI. Being that F813 and D816 are close together, possible
hits for key regions of GpTxI involved with binding include parts of the sequence in which a
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hydrophobic region is followed by a negatively charged region. There is one region of GpTxI
which contains such a sequence, spanning from F5-K8. The sequence of this
hydrophobic/negatively charged pocket is F-M-R-K. These residues have all been shown to
affect the function of GpTxI as a Nav 1.7 inhibitor. Most significantly, the F5A mutation of
GpTxI increased the IC50 for Nav 1.7 6X and the R7A mutation increased the IC50 10X29. The
7th position in ProTxII is W7, which appears to be part of the binding interface in the chimera
crystal structure of Nav 1.7/Nav Ab in complex with ProTxII. However, the nearest positively
charged residue to the 7 position of ProTxII is K4. The K4 residue of ProTxII also is in the
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Figure 51: MST binding curve of GpTxI binding to 𝐍𝐚𝐯 𝟏. 𝟕 VSD with D816A mutation. The calculated 𝐊 𝒅 for this
binding is 6μM, while that for the wild type is 360nM.

Therefore, we suspect that hydrophobic and electrostatic interactions are vital for the
binding of GpTxI to Nav 1.7 VSD-II. The FMRK pocket of GpTxI is a likely candidate of the
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toxin binding site based on the results here (Figure 52). Complementary studies such as HSQC
NMR titrations and binding studies with mutant toxin need to be done to confirm this
hypothesis. In the next section, results of the NMR experiments done with Nav 1.7 VSD and
GpTxI will be discussed. HSQC NMR titrations are performed with the aim of identifying
chemical shift perturbations. Chemical shift perturbations in an NMR titration experiment can
be used to identify residues which are directly involved with binding.

Figure 52: Structure of GpTxI showing side chains of the residues from F5 to K8 . These residues have been
shown to be involved with 𝐍𝐚𝐯 𝟏. 𝟕 binding by electrophysiology studies. According to the results from MST based
mutation studies here, this region would have matching characteristics allowing it to interact with the channel
residues that we have identified as being important for binding.
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Molecular Dynamics Studies of 𝐍𝐚𝐯 𝐑𝐡: A Model System for Studying
Dynamics of VGSCs
Nav Rh is a bacterial VGSC which is unique compared to other bacterial VGSCs for
which the structures are known. This is due to the observation that Nav Rh is an asymmetric
tetramer. Despite being a homo-tetramer based upon primary sequence, the four repeating
units of Nav Rh do not possess a fourfold rotational symmetry about the central pore axis19.
Therefore, the conformational and dynamic properties of Nav Rh are likely to more closely
resemble that of human channels than do the other bacterial VGSCs with published structures.
Since the human VGSCs are made up of four sequence repeats with similar but not identical
sequences, they of course do not poses fourfold symmetry about the central pore axis,
whereas bacterial channels such as Nav Ab do have this high degree of symmetry50. It is of
interest to study conformational properties and free energy landscapes of various processes
undergone by VGSCs. Understanding of such processes at a fundamental level could shed light
on the physical mechanisms and driving forces behind sodium channel activity. Additionally,
analysis of such events could provide a complete picture of the relationship between VGSC
structure and function. One of the main techniques that can be used to study these processes
at such a fundamental level is to use molecular dynamics (MD) simulations. NAMD65 is a MD
simulation program that is well-suited to perform nanosecond time scale simulations of
biomolecules. NAMD can use either AMBER or CHARMM force fields and can handle systems
of greater than 100,000 atoms in an all-atom simulation65 66. The force fields contain all the
major types of potential energy terms that will be experienced by each atom in the system.
Such terms include harmonic restraints on bonds and bond angles, Lennard-Jones potential, and
Coulombic potential energies. The potential energies are felt by each atom in the simulation by
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use of files which contain all information about each residue in the protein and other molecules
such as water, lipids and common ligands. The force field will calculate initial potential energies
and given the relation between potential energy and classical force, F = −∇U (U is the
potential energy and F is the force) the potential energies are numerically integrated to obtain
the force. The force can then be used to find the acceleration (and by integration of
acceleration, the velocities) of each atom using Newton’s second law, F = ma. This process is
repeated at a small time step later (typically in the femtosecond scale), and repeated over again
and again until the desirable time of simulation is reached65.
The Nav Rh system was set up for simulations using the VMD program67. VMD allows
the user to place a membrane protein inside a POPC/POPG phospholipid bilayer and hydrate
with explicit water and ions of chioce67. In this system, 400 mM of NaCl was used along with
the TIP3P model for explicit water molecules68. The Nav Rh system was minimized and
equilibrated. Energy minimization is a simulation that is done after setting up a new system. It
serves to eliminate bad contacts and allows the protein to fall into an energy minimum without
the need for extensive computational resources or time. In the equilibration step following the
minimization, the system is simply allowed to run for 20 ns. Analysis of the time-based RMSD of
the peptide backbone atoms tells one if the protein is stable or not during the equilibration run.
A flat RMSD indicates the protein has become stable69. The Nav Rh system prepared here has a
flat RMSD profile after the equilibration run.

The first advanced simulation that we performed on this system is an ABF (Adaptive
Biasing Force) simulation. An ABF can be used to calculate the free energy of any process that
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occurs in the simulation over a user-defined coordinate. The equations that relate the PMF
(potential of mean force, which can be interpreted as the free energy) with the user defined
coordinate system were first derived by Darve, et al.70 In this study, ABF was used to calculate
the free energy of Na+ ion permeation through the pore of the channel. The user defined
reaction coordinate over which the PMF is calculated for in this study is the channel pore axis.
The Na+ ion begins ~5 Å above the extracellular portion of the channel and the ABF simulation
is run, allowing the ion to permeate through the entire channel pore, while calculating the PMF.
The PMF is directly related to the average force exerted on the ion (in this case) at each point
along the reaction coordinate, whereas the average force is the negative gradient of the PMF.
The PMF is essentially the free energy profile along that reaction coordinate. In the equation
below, F is the force experienced by the particle in question during the ABF simulation, and A is
the PMF (i.e., free energy), and the brackets represent an average over the user defined
coordinate system, ξ (ensemble average).

The average force is easily calculated through the course of the simulation. The PMF is
then calculated from the average force by means of a numerical integration step. Because of
this, the general method of calculating free energy profiles by use of the average force is known
as thermodynamic integration. In an ABF simulation, an additional process is incorporated into
the simulation. The average force calculated at each step is subtracted from the total force
experienced by the particle at each step. This effectively allows the particle to experience
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barrierless diffusion, and the free energy landscape could be sampled without the particle
getting caught in a local energy minimum (known as kinetic traps).
In order to obtain the trajectory frames for which the Na+ ion is traveling through the pore of
the sodium channel for the ABF simulation, we first perform a Steered Molecular Dynamics
(SMD) simulation. The SMD simulation allows one to apply a force to an atom or group of
atoms in a user-defined direction71. During a SMD simulation, all the other potentials of the
force field are still present, with the one exception that an extra force is applied to the atom(s)
of choice. In this study, we run the SMD simulation with a force in the -z direction applied to
one sodium atom, which lies roughly 5 Å above the extracellular pore of Nav Rh . The -z
direction in this set-up is the direction downward through the channel pore toward the
intracellular side. The final output trajectory of the SMD simulation begins with the ion 5 Å
above the extracellular side of the channel and ends with the ion roughly 5 Å below the
intracellular side, thus traversing the entire pore region.
In practice, it is not desirable to run a simulation of much greater than 50-100 ns unless one
has access to highly powerful computational resources. In this study, we aim at running an ABF
simulation in 4 segments (or windows) of 50 ns each. ABF simulations are more efficient when
the reaction coordinate is broken into multiple windows and in each window, the simulation is
run independently of the others. In the end, all the windows are combined in the PMF
calculation. This segmentation of the reaction coordinate into separate windows makes the
PMF more likely to converge to a true free energy profile72.
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Ser 180

Leu 179

Figure 53: VMD (Visual Molecular Dynamics) image of the 𝐍𝐚𝐯 𝐑𝐡 system simulated in this study. In this frame of
the simulation, the 𝐍𝐚+ ion can be seen to interact with the carbonyl oxygen of LEU179 and hydroxyl oxygen of
SER180 of the pore region.

The four windows of the ABF simulation of the Na+ ion permeating through the entire
channel pore were used to calculate the PMF via thermodynamic integration. As could be
expected, we observe local minima in the free energy profile which correspond to the
interactions between the Na+ ion and negatively charged or partial negatively charged species.
We can infer the identity of the specific residues interacting with the ion along the free energy
profile, being that the user defined coordinate is the channel central pore axis. In the free
energy profile shown in
Figure 54, the position along the channel central pore axis is shown on the x-axis and the free
energy on the y-axis. The positions of certain residues which contain oxygen atoms thought to
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make electric dipolar interactions with the Na+ are highlighted along the central pore axis. For
example, we observe a local minimum in the free energy profile in the exact position of the
SER129 side chain in the channel pore. Other minima are observed near the positions of
GLU183, SER180 and THR179, indicating interactions between the Na+ ion and these residues.
The PMF profile has a region near the SER180 which has a constant free energy value extending
over several Angstroms, which is indicative of the PMF not converging to a true value of free
energy for that region. These constants or flat lines in the PMF should not be interpreted as an
interaction or a reversible process, because they are typical of nonconvergence and are
therefore likely to be inaccurate. However, a large portion of the pore axis contains a PMF that
resembles a true free energy. The only other regions containing constants in the PMF are the
regions before and after the Na+ enters or exits the actual pore and is therefore in the bulk
solvent. Therefore, ABF has allowed us to obtain information about specific contacts that are
made between the Na+ ion and residues in the pore domain as it permeates from the
extracellular to the intracellular side of the channel. Depending on the time scales of the
process and the nature of the atomic or molecular species involved, the details that could be
understood by methods such as an ABF simulation may not be paralleled by any experimental
methodology.
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9
Distance from the center of the membrane along the pore axis (Å)
Figure 54: Free energy profile (i.e., PMF) of 𝐍𝐚+ permeation through the pore of 𝐍𝐚𝐯 𝐑𝐡 , calculated using ABF.
The vertical axis if free energy in Å.

Free energy pathways offer great insight into the physics underlying chemical and
biochemical processes. In this study, we have identified specific interactions between Na+ and
residues of the pore domain of Nav Rh , which guide the ion through the pore. There are
seemingly endless processes in biochemistry that would be illuminated by such investigation of
the free energy pathways. The limiting factor in determining the free energy pathways via a
method such as ABF for a biochemical process is as follows. In order to run a PMF simulation
to calculate the free energy pathway by a method such as ABF, one needs not only the
structure of the protein system, but a structure of the system at the beginning and final state of
the process. Of course, there are other ways is which one can model a physical process over
which the free energy calculating simulation is run. If the explicit molecular structures of the
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system in question are not available for both the initial and the final state, there are several
options to proceed. One option is to use the SMD simulation, which applies a force to an atom
or group of atoms in a user-defined direction71. Another method that can be used is to apply an
external constraint force to the system to artificially change the conformation of the protein
based on a known structure. In the simulation program NAMD, the colvars module is a module
that has been implemented to apply external forces and implement free energy calculations.
Colvars allows one to define a collection of atoms as a single variable and then various types of
specialized simulations can be performed on that variable21. One of the simulations that can be
run with colvars on NAMD is the RMSD colvars. The RMSD colvars simulation allows one to
define two sets of atoms. One of the sets of atoms is part of the molecule of interest for which
the free energy of some physical process is being calculated. The other set of atoms would be
part of some reference structure, which can be used as an acceptable model for the final state
of the physical process. The RMSD colvars simulation will apply a potential to the atoms in the
first group in such a way that the RMSD between the first and second group of atoms is
lowered at each step. Eventually, if possible, the coordinates of the first group of atoms will
converge to the coordinates of the second group (reference) atoms. This simulation will
therefore yield a trajectory in which the initial state of the system is evolving to the final state in
a physically acceptable way. From there, free energy simulations such as ABF or Metadynamics
can be performed to calculate the PMF, and therefore the free energy. Deciding which type of
simulation to use to obtain an initial and final state coordinates over some physical process of
interest is highly dependent not only on the nature of the system in question, but also on the
structural information that is currently available for this system. For the sodium ion permeation
pathway, it was reasonable to obtain coordinates for the initial and final state (and states in
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between) using the SMD simulation. Another physical process of great interest involving ion
channels is the conformational transition between an open and closed state.
In this study, we are interested in the conformational transition of Nav Rh from the
open to the closed state. Being that the structure of Nav Rh has been solved in the closed
conformation, we must use another ion channel as a model for the open state structure. The
crystal structure of the voltage-gated potassium channel K v 1.2 has been reported in the open
state conformation73. In this simulation, we aimed to create a model of Nav Rh in the open
state by applying the appropriate constraints to push the pore domain of Nav Rh to the open
state using the structure of K v 1.2 as a reference. In order to do this, we used the colvars
(collective variables) module within NAMD. The RMSD colvars was used such that the collective
variable itself is the RMSD between Cα atoms of Nav Rh pore domain residues and those of
K v 1.2 pore domain residues. In addition, harmonic constraints were applied to the RMSD
colvars over the course of the simulation such as to push the RMSD to a value of 0.1. Harmonic
constraints will apply an external force to the user-defined set of colvars through the course of
the simulation. It is called a harmonic constraint because the form of the external force that is
applied is that of a harmonic oscillator, therefore obeying Hooke’s law. The resulting output
structure of the Nav Rh open state model was then set up and minimized in NAMD with a
POPC bilayer and explicit water solvation. The pore diameter of the Nav Rh open state model
was evaluated in UCSF Chimera74 along with that of the original closed-pore structure by
measuring the distance between the Cβs of Lys 227 from repeat I to that of repeat III. The
Lys227 residue is the second closest residue to the c-terminal end of each pore unit repeat. It
was decided to use this residue as the basis for the pore diameter measurement instead of the
c-terminal end residue, Ile228, because electron density has not been resolved for this residue
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in repeats I and III in the original crystal structure of Nav Rh 19. Figure 55 shows the pore
diameter measurement of the original crystal structure of Nav Rh in the closed-pore state.

Figure 55: Pore diameter of the original crystal structure of Na v Rh , which has been reported to be in the
closed-pore state. The distance was measured between the Cβs of Lys227 from repeat I to that of repeat III,
therefore spanning the pore region. The pore diameter is ~17.5 Å in the closed-pore state.

In the closed-pore state, the pore diameter of Nav Rh is roughly 17.5 Å, as can be seen
in Figure 55. The pore diameter of the Nav Rh open-pore state model generated based on the
method described above was found to be 21.8 Å (Figure 56), significantly larger than the pore
dimeter in the original crystal structure. This is consistent with the suggestion that the openpore state model of Nav Rh generated in this study represents a realistic structure of the
channel in this state. However, further validation would still be needed to be sure that this is
the true open-pore structure of Nav Rh . Future studies that could provide clues as to the
validity of this model include free energy calculations of the closed to open state simulation
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trajectory. Such calculations could be done by ABF, as in the previous study described in which
the free energy of Na+ ion permeation was determined. If the free energy pathway calculated
for the trajectory of Nav Rh from the closed to open pore state appears like a realistic free
energy profile, it would give further validation as to the accuracy of the open-pore state model
of Nav Rh generated in this study.

Figure 56: Pore diameter measurement of the open-pore state model of Na v Rh generated in this study. The pore
diameter was evaluated by measuring the distance between the Cβs of Lys227 from repeat I to that of repeat III,
therefore spanning the pore. The pore dimeter here is ~21.8 Å, while that of the closed-pore original structure is
~17.5 Å.

The RMSD colvars combined with harmonic restraint force simulation allows one to
push a set of atomic coordinates to a set of reference coordinates which represents some
physical process. During the simulation, the potential energy of the transition is kept at
minimum value. That is, the rotation matrix that will transform one set of coordinates to the

99

other with the lowest amount of energy is calculated and the coordinates are then projected
according to that matrix. This makes the simulation likely to be representative of the true
physical process in question. In this simulation, we believe that we have a reasonably accurate
trajectory for the transition of Nav Rh from the closed-pore to open-pore state. In a previous
study, the open state model of Nav Ab was developed in a slightly different way. In that study,
K v 1.2 was also used as the reference coordinates of the open-state pore. However, instead of
colvars, a distance matrix defining the conformational differences in the pore between the two
channels was programed into the course of the simulation75. While this is a more elaborate
simulation for such a process, it requires a high level of computational expertise, such as writing
simulation programs. The method used in this study would only require one to have a basic
practical understanding of NAMD and the NAMD colvars module.
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NMR Investigation of 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II

Introduction
Membrane proteins are notoriously difficult to recombinantly express and obtain in the
correct state for structural determination via any methodology. The entire pseudotetrameric
human NaV 1.7 is too large to gain useful structural information by solution state NMR
spectroscopy. This is because large molecules tumble in solution at a slower rate than smaller
molecules. This tumbling results in an orientational averaging of dipolar couplings between nuclear
spins in the protein to zero. Dipolar couplings are a major source of relaxation and therefore
increasing linewidths in an NMR spectrum. As a consequence, if a molecule is too large, the peaks
in the corresponding NMR spectrum will be broadened beyond detection. This limits the amount
of information one can obtain about specific resides in a protein76. However, many toxins which
are known to bind to and inhibit this channel have been shown to bind to the voltage sensing
domain (VSD) portion only14. Therefore, to gain structural insight into this interaction, it may be
useful to only express one isolated VSD unit of the tetrameric channel. In this study, we expressed
the VSD of the second repeating unit of NaV 1.7. This VSD alone is within a size range feasible for
solution state NMR (14-15 kDa without associated detergents or lipids). The recombinant VSD
was incorporated into phospholipids such as dimyristoylphosphocholine (DMPC) for refolding.
This detergent system is thought to provide conditions which mimic the cell membrane
phospholipid bilayer. This type of system has been widely used for membrane protein structural
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studies77. The protein was expressed in isotopically enriched media, so that 15N and 13C NMR
experiments could be performed. Structural information can be derived from experiments such
as heteronuclear single quantum coherence (HSQC), which can give information about the
chemical environment of directly bonded nitrogen and hydrogen atoms in our protein, and
nuclear Overhauser effect spectroscopy (NOESY) which can give information about the distances
between spin - 1/2 nuclei in space. Combining information from such experiments can be used
to investigate the structure of this protein78.
Protein NMR: Background
HSQC is a 2-dimensional correlation experiment, which gives a spectrum in which each
peak corresponds to two different spin-1/2 nuclei that are directly bonded to each other. The
HSQC experiment relies on an RF pulse sequence in which the spin magnetization is transferred
from 1H to 15N nuclei (or 13C) which are connected directly through bond. As in any 2D NMR
experiment, the amount of time in which the 1H nuclei experience coupling (in this case, scalar Jcoupling) with another nearby nucleus (in the case of HSQC, a 15N or 13C nucleus) in the pulse
sequence is varied in an array of repeated sequences each with a slightly increased value of this
coupling duration. The signal that the 15N contributes is strongest when this duration is shortest,
being that the signal will immediately begin to decay due to relaxation processes. Therefore, as
the coupling duration is increased in each block of the experiment, the 15N contribution to the
signal will lessen, effectively rendering an FID in the indirect dimension. The resulting 2dimensional NMR spectrum will contain peaks that correspond to a nitrogen atom directly bound
to hydrogen. Therefore, each residue of the protein (with the exception of proline) will contain
at least one peak in the HSQC spectrum, due to the amide peptide backbone. Certain residues
will of course contain more peaks, if the side chains contain amines or amides. To obtain
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assignments of the peaks in the spectrum, HSQC alone will not be enough. Many of the peaks
from different amino acids in an HSQC spectrum will have similar values of chemical shift in both
dimensions, making the peaks ambiguous. If one needs to make assignments of all or some of the
residues in a protein, carbon-13 experiments are also necessary. 3-dimensional experiments
involving 1H, 15N and 13C will be necessary for peak assignment of any moderately to large sized
protein (in most practical cases anything above 10 kDa would be considered moderately sized).
It is worth discussing the mechanism by which spin magnetization is transferred from
protons to another nucleus in the HSQC experiment, because this method is also used in most
multidimensional solution state NMR experiments for the same purpose. This method is called
INEPT (Insensitive Nuclei Enhanced by Polarization Transfer)17. INEPT is used to transfer
magnetization from protons to a nucleus with a lower gyromagnetic ratio (i.e., lower sensitivity).
Let 𝐼 be the proton spin operator and 𝑆 be the other nuclear spin operator, which is coupled to
the proton. A 90° pulse on the 𝐼 spin first generates 𝐼𝑦 transverse magnetization. Next, a delay
of

1
2𝐽𝐼𝑆

produces the antiphase operator 𝐼𝑥 𝑆𝑧 . Here, 𝐽𝐼𝑆 is the heteronuclear scalar coupling

constant and the product operator 𝐼𝑥 𝑆𝑧 can be interpreted in a statistical way as follows. The
product operator 𝐼𝑥 𝑆𝑧 represents a probability of the 𝑆 spin to be in the state 𝑆𝑧 , given that the
spin 𝐼 is in the state 𝐼𝑥 79. In the middle of this delay period, 180° pulses are applied to both 𝐼 and
𝑆 to cancel the effect of 𝐼 spin chemical shift evolution, which is necessary to obtain the operator
we seek for at the end of the pulse sequence. Lastly, 90° pulses are simultaneously applied to the
𝐼 and 𝑆 spins. This is the step where magnetization is transferred from the 𝐼 to the 𝑆 spin. The
operator present at this point is the antiphase 𝐼𝑧 𝑆𝑥 operator, representing 𝑆 spin transverse
magnetization. In a plain INEPT experiment, acquisition of signal from the 𝑆 nucleus would
proceed. However, being that the acquisition in this case must be done without decoupling of
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the 𝐼 spin, sensitivity of the spectrum is decreased. If decoupling is used, one needs to have a
standalone 𝑆 spin transverse magnetization operator at the end of the pulse sequence, not the
product operator we have here. A modified version of INEPT called refocused INEPT has been
developed which results in the 𝑆𝑦 operator at the end of the pulse sequence and acquisition can
be obtained on the 𝑆 nucleus with decoupling17. The refocused INEPT is what is most commonly
used in solution state NMR experiments today which require transfer of magnetization from
protons to another spin with lower sensitivity, such as HSQC. This refocused INEPT is a key
building block of many advanced multidimensional NMR experiments.
Multidimensional NMR experiments of proteins have allowed significant advancement of
the biophysics field through the past 25 years. Without these specially designed experiments, the
information that one could obtain about a protein by NMR is limited. An example of one type of
these experiments is the HNCA. In an HNCA, 1H and 15N nuclei can couple, and magnetization
is transferred from the 1H to the 15N nucleus. At this point, the signal is then transferred from
15

N nuclei to neighboring 13C𝛼 , through the 15N-13C𝛼 J-coupling. The pulse sequence is such that

the scalar coupling between 15N and the carbonyl carbon is eliminated, leaving only coupling to
C𝛼 . There are chemical shift evolution periods for both 13C and 15N, and signal is transferred back
to the protons for acquisition. The result after Fourier transform is a three-dimensional spectrum.
The HNCA spectrum will show peaks for three nuclei that are connected via scalar J-coupling.
In this case, most of these peaks will represent an amide proton, an amide nitrogen and the C𝛼
of each amino acid residue in the protein being sampled. As one might imagine, this experiment
can be crucial if one intends on making NMR peak assignments of a moderate to largely sized
protein (see Figure 57).
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Figure 57: HNCA spectrum of a protein, showing the residue assignments. Each strip is a slice of the nitrogen
plane, and the y-axis here is the carbon chemical shift. This part of the spectrum corresponds to the 𝐂𝜶 nuclei
from the peptide backbone.

In this project, we will begin with 1H/15N HSQC experiment. One way to directly
investigate the residues which are involved in binding is to do an HSQC based NMR titration
experiment. In the HSQC titration, the Nav 1.7 VSD will be labeled with 15N and multiple HSQC
spectra will be collected as ProTxII is titrated in. Peaks of the HSQC are likely to undergo a slight
chemical shift perturbation if they are directly involved with toxin binding5. Being that the VSD
we make will be reconstituted in a lipid or detergent complex (as a membrane mimetic), the size
of the complex will be too large for a standard HSQC experiment, and we it will be necessary to
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use transverse relaxation optimization spectroscopy (TROSY) with HSQC. TROSY is used for
large proteins/protein complexes (> 40 kDa) as a way of selectively eliminating certain relaxation
mechanisms from the resulting spectra to obtain much narrower peaks76. This technique has been
invaluable in the field of solution state NMR of biomolecules. Upon obtaining a successful HSQC
spectrum of the NaV 1.7 VSD, other types of solution state 2-dimensional and 3-dimensional NMR
spectroscopy can be used to complement and assign the HSQC. Such techniques, as HNCA or
HNCOCA can be performed in addition to HSQC to obtain 3-dimensional NMR spectra which
have a chemical shift axis for carbon, nitrogen and hydrogen. Such experiments will allow us to
identify residues by making assignments that would not be possible with a 2-dimensional spectrum
alone. Upon completing assignments and having obtained relevant NOESY-based data,
information from these experiments can be fed into an NMR structure calculation program, such
as X-Plor NIH to calculate the 3-dimensional structure of the protein78. When one is performing
NMR studies of larger proteins, there are other experiments that can give useful structural
information besides NOESY spectra alone. Among the most commonly used of these are residual
dipolar couplings (RDCs) and paramagnetic relaxation (PRE).
Advanced Structural Analysis by NMR:
RDCs occur when the molecular system under investigation exhibits partial alignment
while the NMR experiment is being conducted. Typically, in solution state NMR, the solute
molecules are tumbling at high rotational speeds. The direct dipolar interaction between nuclear
spins is a strong interaction in NMR experiments, which dominates in solid state experiments.
The dipolar coupling is a direct interaction between the magnetic fields produced by two spins
that are nearby in space; the interaction is proportional to 𝑟 −3, where 𝑟 is the radial distance
between the two nuclei80. In solution state NMR, the expression for the dipolar interaction must
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be averaged over time to account for the fluctuation of the angular dependence on the interaction
over the time scale of the NMR experiment. We obtain an expression as:

𝐷𝑖𝑗 =

𝜇0 𝛾𝑖 𝛾𝑗 ℎ 3𝑐𝑜𝑠2 𝜃−1
(2𝜋𝑟)3

〈

2

〉

In the above, 𝐷𝑖𝑗 is the dipolar coupling between nuclei, 𝛾𝑖 and 𝛾𝑗 are the gyromagnetic ratios of
the two nuclei, 𝜇0 is the free space permittivity, θ is the angle between the two spins and the
brackets arounds the angular part of the expression indicate an average over time 80. When
molecules in solution are isotropically tumbling, the angular term in the brackets averages to
zero, thus the dipolar interaction is zero. When partial anisotropy of the solute molecules is
exhibited, the term in brackets is not completely averaged to zero, this is what we call residual
dipolar coupling. Clearly, the properties of either the solute or the solvent must somehow
facilitate the condition of partial solute anisotropy. Practically, this can be done in a few different
ways. One of the most feasible ways to induce partial alignment of a solution state NMR sample
comprised of membrane proteins is to use bicelles. Bicelles are formed from mixtures of long
chain and short chain phospholipids in specific molar ratios. The resulting molecular assembly
resembles a disc comprised of a phospholipid bilayer52. The incorporation of membrane protein
into bicelles can result in partial anisotropy of the molecules in solution, depending on the size
and anisotropy of the bicelles themselves. Other methods for creating partial alignment of the
solute molecules include the use of other additives to the solution sample such as stretched
polyacrylamide gels or PEG (poly-ethylene glycol)81. Once the partially aligned sample is prepared,
one can obtain useful information regarding the orientation of the molecule under investigation
by NMR. There are several different types of available NMR experiments one can use to measure
RDCs. Among the first developed was a modified HSQC experiment in which the values of 1H107
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N RDCs are encoded into the peak intensities. Currently, there are modified forms of 3-

dimensional experiments available that can be used to measure 1H-13C,
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C-13C, and

15

N-13C

RDCs80.
The NMR structure calculation program, XPLOR NIH is able to use RDCs among other
constraints to calculate the structure of a protein from NMR data via simulated annealing37. The
XPLOR package offers a robust variety of user defined restraints that help improve the accuracy
of a structure calculation. The standard restraints that are used in such a calculation are the NOE
based distance restraints and the dihedral angle restraints. The NOE distance restraints are
ultimately derived from the intensity of NOE cross-peaks in the NMR spectrum. The NOE
experiment relies on the mechanism of dipolar cross relaxation between spins which are close
together in space. This mechanism describes how the energy level of one spin system can affect
that of another which is a short distance away, upon the generation of coherent signal17 The cross
peaks in the NOE spectrum will thus be from nuclei which are close together in space. In practice,
it is typically seen that the NOE cross peaks will be seen from nuclei which are within 5 Å of one
another. The intensity of the NOE cross peaks will diminish with distance, it is proportional to
1
𝑟6

where 𝑟 is the radial distance between the two nuclei17. The XPLOR NIH program will take

user defined pairs of NOE peaks from an assigned NMR spectrum along with the intensities to
define an energy term in the simulation force field, known as the NOE potential 37. This potential
energy term is one of the main restraints used to calculate the structure of biomolecules by
solution state NMR. Another restraint used by a structure calculation program such as XPLOR
NIH is the dihedral angle restraint. Programs such as TALOS will estimate the dihedral angles of
the peptide backbone based largely on 13C chemical shift values. This is done by referencing the
13

C chemical shifts of the protein under investigation to those of proteins known in the protein
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data bank (PDB), of which the conformation of the backbone is known82. The carbon chemical
shifts will be known upon assignment of the 3-dimensional NMR experiments such as HNCA or
HNCOCA. This data is then fed into the TALOS program, which then generates the predicted
dihedral angles between residues in the protein. The XPLOR-NIH structure calculation program
will take dihedral angles generated by TALOS and use them as restraints in the simulated
annealing calculation. This is a very important parameter which is necessary for accurately
determining the structure of a protein (see Figure 58).

Figure 58: Illustration of a general peptide backbone, which shows the dihedral angles φ and ψ. The two angles
are classified as dihedrals because they are the angles between two planes. The planes are formed from the amide
group of the peptide backbone, which is locked into planar conformation due to the carbonyl π-bond resonance
with the nitrogen. These angles are a crucial component to the structure of proteins.

There are additional restraints that can be used by structure calculation programs such as
XPLOR-NIH to help solve the structure of large proteins. The major distance restraint that can
be obtained by solution state NMR are the NOE restraints, as mentioned previously. However,
in some cases the NOE distance restraints will not give enough information to accurately calculate
the structure of large proteins. This is due to the short distance cutoff, which is roughly 5 Å for
NOEs. If one is interested in obtaining information about larger distances in the structure, a very
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useful technique that can be used by solution state NMR is the paramagnetic relaxation
enhancement (PRE) restraint. PRE requires the labeling of certain side chains of the protein with
a paramagnetic spin label (typically done using a nitroxide group). The paramagnetic spin label will
cause the nearby nuclear spin states to undergo 𝑇2 relaxation at a much faster rate than without
the spin label. Therefore, distances between nuclei in the protein and the spin label can be
determined. For instance, if the chemistry used is such that all cysteines get linked to the
paramagnetic spin label, distances of the cysteines from the other residues can be determined by
PRE, even if the distance is significantly greater than 5 Å83. The determination of distances via PRE
relies on an equation known as the Solomon-Bloembergen-Morgan equation, which relates the
𝑇2 transverse relaxation rate with the distance between a nucleus in the NMR spectrum with the
paramagnetic spin label. An NMR experiment must also be run of the sample without the
paramagnetic spin label in order to know the paramagnetic relaxation enhancement, as opposed
to just the normal nuclear 𝑇2 relaxation83. This paramagnetic relaxation enhancement is a factor
in the Solomon-Bloembergen-Morgan equation (Figure 59), and therefore must be known if one
is to extract distances from equation. The Solomon-Bloembergen-Morgan equation stems from
one of the original Solomon-Bloembergen equations which was among the first developed
theories to offer a quantitative explanation of nuclear spin relaxation. Such theories were derived
under simplified conditions, under which there is only a single 𝐼 − 𝑆 spin pair with no additional
sources of dipolar coupling84. The presence of a nearby electron spin from the paramagnetic
species has an effect on the relaxation of the nuclear spin state. There are a number of
contributions of this enhancement of nuclear relaxation of a nuclear spin by a nearby unpaired
electron, including specific orientational fluctuations and the electron’s own relaxation85. Modern
theories of paramagnetic enhanced relaxation are complicated, but one can determine the
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paramagnetic enhancement factor experimentally by comparing the relaxation of a certain nuclear
spin in the unlabeled diamagnetic sample to that of the paramagnetically labeled sample. In this
way, one can generate a set of distance restraints with PRE data which can be applied in a
structure calculation program such as XPLOR-NIH in a similar manner as NOE distance
restraints.

Figure 59: The Solomon-Bloembergen-Morgan equation which relates the radial distance between an unpaired
𝒔𝒑
electron and a spin-1/2 nucleus in the sample under investigation. 𝑹𝟐 is the paramagnetic relaxation enhancement
factor, which is found by dividing the intensity of a signal from the paramagnetic-labeled sample by that of the
unlabeled diamagnetic sample. Also, 𝝉𝒄 is the rotational correlation time of the molecule in question, which can
also be determined experimentally.

There are several techniques for obtaining structural and dynamic information about
proteins by solution-state NMR that are currently available. The choice of techniques needed will
be highly dependent on the nature of the molecular system under investigation. If one is interested
in solving the structure of a small peptide (roughly 2-4 kDa), it is possible to obtain the necessary
information with homonuclear 1H NMR alone. With larger proteins, clearly one needs the use of
13

C and 15N isotopic labeling to obtain the information necessary to make resonance assignments

and attempt to calculate the structure. However, this labeling scheme may not be enough to
obtain high quality NMR spectra from larger proteins (30 kDa and above, depending on the
system). In the past two decades, the use of 2H labeling for NMR experiments of larger proteins
has emerged as an invaluable tool for the structural investigation of these molecules. The
advantage of 2H labeling for large proteins is as follows. One of the primary mechanisms of
relaxation in a protein is due to the 1H-1H dipolar relaxation or the 1H-13C heteronuclear dipolar
relaxation. In a classical picture of the dipolar interaction, we view the nuclear spins as magnetic
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dipoles and the interaction between two magnetic dipoles is given as the interaction known from
classical electrodynamics. This value is equivalent to the expression for 𝐷𝑖𝑗 written previously in
the discussion of RDCs. Even though the net value of the dipolar interaction is averaged to zero
by a tumbling molecule, the individual dipolar interactions between nuclei in the molecule are still
present. The result of this is the presence of locally fluctuating magnetic fields due to these
interactions. As is well know from the classical theory of NMR, relaxation is primarily caused by
local fluctuations in magnetic field experienced by the nuclei in the system86. The relaxation rates
of

13

C are therefore drastically affected by nearby protons. When the protein of interest is

deuterated, the gyromagnetic ratio is decreased by roughly 6.7 times that for protons. This causes
the signal sensitivity to decrease, and therefore the effect of cross-relaxation for deuteriumcarbon is decreased as compared with proton-carbon. The overall effect is that multidimensional
NMR experiments, particularly those involving carbon, will have much sharper peaks as compared
with a non-deuterated sample87. Common three-dimensional protein NMR experiments can still
be performed on a recombinant protein which is grown in D2O medium, because such
experiments only rely on the exchangeable amide proton being present. Therefore, if the NMR
sample buffer is mainly H2O, such experiments will ensue as normal, only hopefully with sharper
peaks. However, the use of a deuterated protein will restrict the number of NOEs that could be
obtained from that protein. For instance, if one is interested in obtaining HN-methyl proton
NOEs between a backbone amide and the methyl protons of a nearby valine, leucine or isoleucine
residue for distance restraints, a fully deuterated protein cannot be used. Methods are available
if there is such need for additional structural restraints in solution-state NMR of large proteins.
The protein can be selectively protonated at side chain methyl groups while the rest of the protein
is deuterated by the addition of metabolic intermediates to the growth media. Compounds that
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can be added for this use include [3,3-2H2] α-ketobutyrate and [3-2H] α-ketoisovalerate. Both
compounds will result in proteins that only have methyl protons of side chains containing methyl
groups protonated when supplemented to the growth medium87.
When one is performing 3-dimensional NMR experiments on proteins, particularly if the
concentration is low, the number of scans needed to obtain high quality spectra could be
unfeasible. The amount of NMR time that a research group can use in a given period is often a
limited resource. An invaluable technique has been developed in which an NMR user can obtain
the high-quality spectra that they would with many scans in significantly less time. This technique
is known as non-uniform sampling. In non-uniform sampling, the time points of the indirect
dimension are not all collected as usual, but some of these points in between the first and the
last are skipped. Each point that is skipped in the indirect dimension reduces the amount of time
the experiment needs to be completed. However, the resulting 2 or 3-dimesnional NMR
spectrum cannot be processed as usual. Fourier transform of the indirect dimension will result
in meaningless results, being that many of the time points in that dimension were not collected.
Methods are available to reconstruct the missing data from non-uniformly sampled NMR
experiments. One such method is known as Iterative Shrinkage Thresholding (IST), which is
supported by the NMRPIPE processing program35. The NMR experiment being run using NUS
has two main user-defined parameters which can be changed based on spectrometer time
availability and type of experiments being conducted. One of these parameters is the sparsity,
which defines how much of the indirect dimension is collected compared to the full set of data
points in the corresponding experiment without using NUS. In this study, we use a 50% sparsity
for the NUS experiments, which means that half of the points in the indirect dimension are
collected. The other user-defined parameter of significance in NUS is the sampling scheme.
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Sampling schemes which have patterns have been designed for specific types of experiments,
depending on the needs of the spectroscopist. For example, some sampling schemes place more
weight on the earlier time points in the FID, before the exponential decay has had a substantial
impact on the signal. These types of sampling schemes can offer an increase in sensitivity. There
are other sampling schemes in which the data points collected are randomly distributed across
the FID. Sampling schemes of this type will help prevent artifact data which can sometimes be a
result of NUS data reconstruction88. Many of the HSQC studies performed in this study were
run with NUS for time-efficiency and processed with NMRPIPIE using IST. This will also be
extensively used for 3-dimensional experiments done in future studies.

HSQC Studies of 𝐍𝐚𝐯 𝟏. 𝟕 -VSD-II in LMPC Detergent Micelles
Procedures:
Nav 1.7 VSD-II was expressed, purified and refolded as described in chapter 2, with the
addition of 15N ammonium chloride (Cambridge Isotopes ™) in the M63 growth medium instead
of normal ammonium chloride. The resulting VSD in LMPC micelles was used for NMR
experiments using a 600MHz Varian ™ spectrometer. All NMR experiments were performed at
42°C and pH 6.8 with 5% D2 O. 15N HSQC TROSY experiments were performed using 64 scans.
Proton 90° pulses were calibrated prior to each experiment, along with standard shimming
procedures. Concentration of LMPC was determined by 1H NMR performed of the sample prior
to HSQC experiments. The phosphocholine quaternary amine peak of LMPC in the VSD sample
was quantitatively compared with that of a standard sample containing 100 mM LMPC. Solid
LMPC was added to the VSD sample in accordance with the amount needed according to the
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quantitative 1H NMR comparison to the LMPC standard. HSQC data was processed using
NMRPIPE ™.
In this study, the Nav 1.7 VSD was produced and exchanged into LMPC micelles as
described in the expression and purification chapter. The optimal sample conditions for NMR
were determined by varying temperature, pH and LMPC concentration. In each NMR experiment
performed in this study, 15N labeled protein was used and HSQC-TROSY experiments were
collected for each condition being tested. All the following NMR experiments were performed
on a 600MHz Varian spectrometer. The resulting data were processed via NMRPIPE.

HSQC Studies of 𝐍𝐚𝐯 𝟏. 𝟕 -VSD-II in LMPC Detergent Micelles Results:
It was initially determined that the detergent concentration should be optimized at pH
6.8 and 42°C. That is because that temperature/pH combination had resulted in the best HSQC
spectrum in a preliminary round of experiments. Importantly, the concentration of LMPC has a
drastic effect on the quality of the HSQC spectra of the VSD. The LMPC concentration of the
initial VSD NMR sample prepared was 100 mM and after each experiment, the concentration was
increased by 100 mM until reaching a maximum of 600 mM. This range was chosen with some
guidance from a 2017 publication which involved the optimization of NMR conditions for a
Nav 1.4 VSD in detergent micelles89. Standard shimming and calibration of proton p90 pulses was
done in between each sample, but all other acquisition and processing parameters were kept the
same.
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The sample containing 100 mM LMPC exhibited a poor 15N HSQC spectrum (Figure 60).
There should be at least 140 peaks (the number of amino acids in the VSD produced here),
instead there are less than 20 defined peaks and others which are just above the noise level. The
HSQC

Figure 60: 15N HSQC NMR of Nav1.7 VSD-II in 100mM LMPC. Experiment was performed at 42°C, pH 6.8.
There are very few peaks compared to the number that should be present for the VSD (>140). 100mM LMPC is
not an optimum condition for VSD NMR studies.
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Figure 61: 15N HSQC NMR of Nav1.7 VSD-II in 200mM LMPC. There is a clear improvement in the quality of the
spectrum as compared with that of the VSD in 100mM LMPC. We continue the detergent titration in effort to
seek further improvements in spectral quality.

spectrum of the VSD in 200 mM LMPC displays clear improvements in spectral quality (Figure
61). Not only does the number of peaks increase, but the intensities of most peaks increase.
There is an improved signal to noise ratio and peaks can be seen which were not at all visible in
the HSQC spectrum of the VSD in 100 mM LMPC. We suspect that 100 mM LMPC is not enough
detergent to provide a stable system for the VSD. It is possible that the VSD is at least partially
aggregated in 100 mM LMPC. It is apparent that increasing the detergent concentration provides
a more suitable environment for the VSD, based on the HSQC data. In any case, the detergent
titration is continued to seek further improvements in spectral quality. The next detergent
concentration
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Figure 62: 15N HSQC NMR of Nav1.7 VSD-II in 300mM LMPC. We see improvements in the spectral quality for
this detergent titration point as compared with the 200mM LMPC sample. This spectrum contains the greatest
number of peaks out of the three concentration points tried at this point along with increased peak intensity.

titration point tested in this study is 300 mM LMPC. The HSQC spectrum of the Nav 1.7 VSD-II
in 300 mM LMPC is of the highest quality tested yet (Figure 62). Improvements in the spectrum
in 300mM LMPC can be seen as compared with the HSQC of the VSD in 200 mM LMPC. Many
peaks have higher intensity and there is a greater number of peaks. In all, it appears that as the
LMPC concentration is increased, the overall quality of the HSQC spectra is increasing. As in the
improvement of spectral quality from 100 mM to 200 mM LMPC, we suspect that the increased
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Figure 63: 15N HSQC of Nav1.7 VSD-II in 400mM LMPC. There is a slight decrease in spectral quality for this
HSQC as compared to the spectrum taken with 300mM LMPC. The peak intensity in general decreases slightly and
the signal to noise is somewhat worse.

VSD in solution. The HSQC was also performed on the VSD in 400 mM LMPC. Interestingly,
the HSQC taken of the VSD in 400 mM LMPC is of slightly less spectral quality than that using
300mM LMPC (Figure 63). There is an overall slight decrease in peak intensity and signal to noise
ratio in the 400 mM LMPC sample. Next, an HSQC was performed on the VSD in 500 mM LMPC.
The 500 mM LMPC condition does not offer any improvement in spectral quality over that taken
at 400 mM LMPC (Figure 64). Another HSQC was collected of the VSD in 600 mM LMPC. There
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is an apparent decrease in spectral quality of the VSD using 600 mM LMPC (Figure 65). The
number of peaks and the overall intensity of the peaks decreases going from 500 mM to 600 mM
LMPC. Therefore, we conclude that 300 mM LMPC offers the best detergent concentration for
NMR of Nav1.7 VSD-II produced by the methods performed in this study. All further NMR
experiments conducted on the VSD in this study will be done so using 300 mM LMPC.

Figure 64: 15N HSQC spectrum of Nav1.7 VSD-II in 500 mM LMPC. There is an apparent decrease in spectral
quality compared with the HSQC at 300 mM LMPC. This spectrum is similar to that taken at 400 mM LMPC,
however the 300 mM LMPC spectrum remains to have the highest quality of the detergent concentration points
attempted.
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Figure 65: 15N HSQC of Nav1.7 VSD-II in 600 mM LMPC. The quality of the NMR spectrum is diminished from
that of the VSD in 500 mM LMPC. This is therefore the highest detergent concentration attempted in this titration
and 300 mM LMPC will be used for all further solution-state NMR experiments on the VSD in this study.

HSQC NMR Titration: 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II and GpTxI Procedures
In the previous round of experiments, we had found that the optimal concentration of
LMPC for NMR experiments on the Nav1.7 VSD is 300 mM, while the sample is at 42°C. With
these conditions, the next task we performed is a titration of GpTxI into the NMR sample
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containing 225 μM of 15N-labeled VSD in 300 mM LMPC. The titrations were done according to
molar ratio of GpTxI:VSD. The ratios that were used in this titration were 1:1, 2:1 and 4:1.

HSQC NMR Titration: 𝐍𝐚𝐯 𝟏. 𝟕 VSD-II and GpTxI Results
The parameter that is determined in an HSQC based titration is the chemical shift
perturbation. If distinct chemical shift perturbations systematically increase (in whatever
direction the original shift is in) with increasing toxin concentration, then it is highly likely that
the residue corresponding to that peak is involved in toxin binding. This makes the HSQC
titration a vital experiment in determining the first molecular details about the binding interface.
Once distinct chemical shift perturbations have been identified, more advanced NMR
experiments could be performed to obtain more information about the binding interface. Such
experiments include the X-half filter NOESY which gives intermolecular NOEs (and therefore,
distances) and dynamics of binding can be investigated by 15N and 13C relaxation experiments90.
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Figure 66: 15N HSQC of Nav1.7 VSD-II in 300 mM LMPC. Experiment was performed on a Varian 600MHz
spectrometer at 42°C. The peak-count is ~225, while there are only ~140 residues in this VSD. We suspect there
to be some conformational heterogeneity within the sample.

The HSQC experiments performed on the VSD in this study were conducted on a
600MHz Varian spectrometer at 42°C at pH 6.8. All the experiments were performed under
NUS with 224 scans for improved sensitivity and reasonable amounts of spectrometer time
needed. The data was collected using a random sampling scheme with 50% sparsity. The NUS
data was reconstructed and processed using NMRPIPE based IST. The spectrum with no toxin
(figure 66) indicates the presence of conformational heterogeneity. Conformational
heterogeneity can result in an NMR spectrum which contains more peaks and/or broader peaks
than in the spectrum from the same sample which is conformationally homogenous. If the
dynamics of the conformational switching is fast, the peaks will appear to be sharp and located
at the average value of chemical shift between the two (or more) conformational populations. If
there is intermediate exchange, the peaks will be broadened. During the case of slow exchange,
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there will be a distinct peak from each conformational state at their respective chemical shift
values91. The HSQC spectrum of the VSD here appears to have a combination of fast
exchanging (from the more flexible regions) residues and intermediate exchange regions. The
extracellular loops, for example, are likely to be flexible and quite dynamic in the fast-exchange
regime. We could speculate that the transmembrane regions which are buried inside of the
LMPC micelles are more constrained and do not exchange conformations in the fast-exchange
regime, but it the intermediate-exchange regime. Further studies (such as PRE) would be
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needed to help confirm this, however.
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Figure 67: 15N HSQC spectrum of Nav1.7 VSD-II with GpTxI in a 2:1 toxin:VSD molar ratio. The number of
peaks from the VSD decrease compared to the spectrum with no toxin present. This decrease is from ~225 to
~175. Therefore, we suspect that toxin is acting to stabilize the conformational inhomogeneity of the VSD.
Chemical shift perturbations due to binding are very difficult to discern in this case, being that many of the peaks
appear to be shifting due, likely due to the conformational stabilization effect of the toxin.
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Interestingly, the addition of 1:1 toxin: VSD did not show an appreciable difference in
the HSQC spectrum as compared to that of the VSD without the presence of GpTxI.
However, the addition of toxin with a 2:1 molar ratio of toxin:VSD resulted in a significantly
different spectrum (Figure 67). The 2:1 HSQC spectrum contains less peaks than the spectrum
of the VSD without toxin does. The number of peaks decreases from roughly 225 to roughly
175. Many of the peaks in the 2:1 spectrum also appear to be sharper than those in the
spectrum of the VSD without toxin. This indicates that the toxin influences the conformational
flexibility of the VSD in solution. Distinct chemical shift perturbations could not be identified, as
most of the peaks appear to shift due to the suspected conformational stabilization effect of the
toxin. Finally, we have performed the same HSQC experiment on the Nav 1.7 VSD-II with a 4:1
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Figure 68: 15N HSQC spectrum of Nav1.7 VSD-II with 4:l molar ratio of toxin:VSD. Many of the peaks are sharper
than in the corresponding 2:1 spectrum shown in the previous figure. We suspect that the toxin is binding to the
VSD and locking it into one conformation.
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The HSQC spectrum of the VSD with a 4:1 toxin:VSD molar ratio appears to have the
most conformational homogeneity of all the samples run in this HSQC titration experiment
(Figure 68). In general, the peaks are sharpened as compared to the HSQC spectrum obtained
using the 2:1 ratio. These results indicate that the toxin binds to the VSD and locks it into one
conformation. The VSD prepared in this study most likely exhibits conformational changes
dynamically in LMPC micelles, as indicated by the HSQC spectrum of the VSD without toxin.
We suspect that there is a combination of intermediate and fast exchange dynamics, likely
dictated by local flexibility. However, the addition of toxin not only reduces the number of
peaks in the spectrum, but it also causes many of the broad peaks to become sharper. This
indicates that the toxin binding is having a substantial impact on the conformational flexibility of
the VSD (see Figure 69). The MST binding studies performed in this work have shown that
residues in the region of the S3/S4 loop (paddle motif) of the VSD are crucial for GpTxI binding.
The HSQC titration experiment performed here supports the claim that GpTxI binds to the
S3/S4 extracellular loop resulting in the stabilization of a single conformation. In all, we suspect
that the addition of a molar excess of toxin could be a necessary step for obtaining useful NMR
data from the Nav1.7 VSD-II in LMPC micelles that we have prepared in this study.
Unfortunately, even though the addition of toxin does increase the quality of the NMR
spectrum in terms of potentially being able to make resonance assignments, some further
improvements would also likely be necessary. Due to the presence of low-intensity signals
which are near the level of normal noise in NMR spectra, it would in practice be quite difficult
to make resonance assignments upon performing 3D experiments. The number of low-intensity
peaks which are near the noise level will only increase when performing a 3D experiment, such
as an HNCA, as compared to those of an HSQC. Therefore, future studies will entail further
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optimization of the NMR conditions for the VSD. Such conditions include testing combinations
of different detergents at various ratios to form a composite micelles system. One type of
detergent alone may not allow the VSD to be as stable as needed for obtaining high-quality
NMR data for advanced structural studies. While the addition of toxin is most likely increasing
the conformational stability of the VSD in this system, that is not to say that other regions of
the VSD are also quite dynamic and lacking defined conformation. Such regions could be
responsible for peaks which have apparent low intensity, due to extensive peak broadening. If
an NMR signal is broadened enough, it will eventually approach an intensity of zero which
would be seen as damping and eventual disappearance of the signal in the NMR spectrum. It is
suspected that HSQC experiments of the VSD should be tested in combinations of various
detergents to find a system which provides a stable landscape for the VSD to adopt a single
conformation. LMPC did appear to be more compatible with the VSD than other detergents
such as DPC (dodecylphosphocholine) and DDM (dodecylmaltopyranoside) since exchanging
the VSD from DMPC into those detergents resulted in the VSD precipitating out. However, it
is highly possible that LMPC is needed to initially extract the VSD from the DMPC complex and
then the addition of other detergents could provide a composite micelle system in which the
VSD is more conformationally stable. In future studies, this will be attempted for solution-state
NMR studies. In addition, solid-state NMR studies will be performed on the VSD after
lyophilized in the DMPC complex.
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Figure 69: Close-up view of overlay of the three HSQC spectra in the titration. Red indicates VSD with no toxin,
blue is 2:1 and green is 4:1 toxin:VSD. As can be seen, there are no distinctive chemical shift perturbations which
one could potentially use to identify residues that are directly involved with binding. However, it appears that the
toxin reduces the conformational heterogeneity of the VSD in micelles. It can be seen that the number of peaks
and the broadness of the peaks both decrease as toxin is added.
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Summary:

In summary, we have designed an expression/purification/refolding procedure to
produce an isolated VSD from Nav 1.7 in a native-like state. In addition, we have found that the
residues F813 and D816 of the VSD are likely to be directly involved with GpTxI binding,
shown by MST binding studies with VSD mutants. The crystal structure of Nav 1.7 VSDII/Nav Ab chimera supports that F813 and D816 are involved with binding between Nav 1.7 and
ProTxII. This suggests the possibility that there are similarities between the binding modes of
GpTxI and ProTxII towards Nav 1.7 . This begs the question of how similar the structures are
between GpTxI and ProTxII. As can be seen in Figure 70, there are structural similarities
between the two toxins. This is not terribly surprising, being that they are both gating modifier
toxins from tarantulas. The backbone RMSD between these two structures is 1.1 Å, calculated
using UCSF Chimera74. This tells us that the structures are highly similar. As can be seen in the
primary sequence alignment shown in Figure 71, the sequences are roughly 30% identical.
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Figure 70: Structural alignment of GpTxI and ProTxII, performed using UCSF Chimera 74. The structures are
largely similar, except for the loop region near the N-terminus. Both toxins have the same disulfide bonding
framework and have a region with β-sheets from the center to the c-terminus.

There are some distinctive differences in the primary sequence between the two toxins,
however most of the hydrophobic residues of the core portion align by type even if not exactly.
The N-terminus of ProTxII has positive charge, while the N-terminus of GpTxI is negatively
charged. In addition, the C-terminus of ProTxII has a higher positive charge density than that of
GpTxI. Following the third disulfide bond in the C-terminal loop, ProTxII has three consecutive
lysine residues, while GpTxI has only one lysine residue. Despite these differences at the
termini, the overall charge densities are very similar: ProTxII has a pI of 8.89 and GpTxI has a pI
of 8.9092. Interestingly, the regions which are most different between these two toxins are the
N and C-termini. These differences could have a large impact on the overall pathophysiological
and physical properties of the toxins.
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Figure 71: Primary sequence alignment of GpTxI and ProtxII, performed using Clustal Omega 42. There are some
major differences in the primary sequences of the two toxins. The largest differences occur at the termini. For
instance, the N-terminus of ProTxII is positively charged, while that of GpTxI is negatively charged. Despite this,
the overall charge density of the toxins are similar.

According to Xu, et. al., part of the binding interface between ProTxII and Nav 1.7 VSDII comes quite near the N-terminus of ProTxII. In particular, the residues W5 and M6 of
ProTxII are thought to make direct contacts with residues of the VSD4. Given that the charge
density profiles of the N-termini of these toxins are different, the exact mechanism of how the
toxins bind to the VSD could be somewhat different. However, based on our binding studies
with mutant Nav 1.7 VSD with GpTxII and the results from Xu, et al. and Shen, et al., we
suspect that types of interactions involved with binding and the overall binding modes are likely
to be similar between the two toxins.
We have also optimized the concentration of LMPC detergent for NMR studies of
Nav 1.7 VSD-II in micelles and subsequently performed a HSQC titration of the VSD with
GpTxI. The HSQC titration experiment indicates that there is a conformational change or the
collapse of a multi-conformational ensemble into a singular conformation upon the addition of
toxin. Of course, the VSD itself is known to undergo significant conformational rearrangements
in the intact channel during voltage gating. Together with that intrinsic conformational flexibility
of this protein domain, we suspect that the VSD could be constrained in the LMPC micelles, in
such a way that it can only fluctuate between local minima in the conformational free energy
landscape, rather than fall into an absolute minimum state which normally occurs during protein
folding. For example, the helices could be dynamically fluctuating between being positioned
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further inside the hydrophobic core of the micelle and further outside the micelle, where they
will be exposed to the solvent. Since the transmembrane helices are largely hydrophobic, they
will make favorable contacts with the alkyl chains of LMPC while positioned further inside the
micelle core. However, if the micelle interior does not provide enough space for the four VSD
helices, steric energy will increase. While the movement of the helices to a position which is
further outside the micelle core will likely reduce the steric energy, the favorable interactions
with alkyl chains of LMPC will then be substituted for unfavorable interactions with water. Both
of the former states would not correspond to an absolute minimum energy configuration such
would be adopted by the VSD in a cell membrane. Additionally, there could be scissoring
motions between the helices of the VSD in micelles and possibly other modes that contribute
to the dynamic fluctuation between conformational states of the VSD in micelles. The toxin
likely provides some stabilization of one of the conformational states that the VSD is fluctuating
between and therefore the VSD will collapse into a singular conformation in the ensemble. For
instance, we know from the mutation studies that a hydrophobic interaction (among others) is
involved with binding between the VSD and GpTxI. If the VSD in micelles is in the state in
which the helices are facing further outside the core of the micelles, the hydrophobic
interactions that are otherwise broken could be maintained due to the presence of a
hydrophobic side chain from GpTxI in the binding pocket. However, we cannot conclude the
former from the experiments we have done in this study alone. One study that would help
prove what we suspect is the PRE experiment, discussed in chapter 5. Detergents are available
which have paramagnetic labels on either the alkyl chain or the polar head group. If one has
resonance assignments of hydrophobic side chain protons and/or 13C nuclei, it can be seen if
these side chains are moving closer or further away from the micelle core using the
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paramagnetically labeled detergent and performing PRE experiments with and without toxin
present. Of course, for one to have such assignments made, 3-dimensional NMR experiments
must first be performed on the VSD. This is a future study that will naturally follow the work
done here. The quality of the HSQC spectra of the VSD indicates that we still may need to
perform some fine-tuning of the detergent optimization. There are still some peaks which are
difficult to distinguish against the noise, which could bring some major difficulties during peak
assignment. We suspect that a combination of detergents could provide a more suitable system
for NMR studies of the VSD. While LMPC would still be the initial detergent from which the
VSD is extracted from DMPC, the addition of one or a few other detergents may suitably
change the size of the micelle to provide a more stable environment for the VSD. As can be
seen in the HSQC titration experiment of the VSD with GpTxI, there is likely to be
conformational heterogeneity of the VSD which is somewhat stabilized by the addition of toxin,
as previously described. If the micelle interior has a greater volume upon addition of other
detergent(s), this could allow us to overcome the issues we believe are causing the
conformational heterogeneity. Once a detergent composition is found which reduces the
number of peaks that are indistinguishable from the noise, 3-dimensional NMR experiments
such as HNCA and HNCOCA can be performed to make resonance assignments. From there,
3-dimensional experiments with NOE can be performed and resulting data can be used to solve
the NMR structure of the VSD in complex with toxin. Additionally, NMR relaxation
experiments can be performed to obtain dynamical information regarding toxin binding10.
In this work, we have also established an explicitly solvated Nav Rh system in a POPC
bilayer for MD simulations. Subsequently, we have performed a free energy calculation on
sodium ion permeation through Nav Rh using SMD and ABF simulations. Additionally, we have
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used RMSD colvars in addition to harmonic constraints were used to generate an open-pore
state model of Nav Rh
Future studies include performing a free energy calculating simulation of the closedopen state trajectory using a method such as ABF or metadynamics. Metadynamics is a method
which applies gaussian potential energies to a set of user-defined colvars in a memory dependent
fashion. The metadynamics simulation essentially constructs these gaussian hills over the course
of the free energy landscape and allows one to find the true local minima over the process
being investigated93. This method is a good candidate to attempt exploring the free energy
landscape of the S6-helix motion from the closed to the open state in our model trajectory for
Nav Rh . This would also help to validate the trajectory that we have obtained using the RMSD
colvars with harmonic constraints applied. If the free energy profile obtained by running a
metadynamics simulation over the trajectory (defining C𝛼 backbone atoms of S6 as the colvars)
converges to a physically realistic free energy profile, it is likely that this trajectory is
comparable to the conformational motion of the pore of Nav Rh from the open to closed state.
Lastly, we have solved the solution-state NMR structure of the novel Terebrid toxin,
Tsu1.1. Tsu1.1 is designated as a framework I of conotoxins/terebrid toxins due to the primary
sequence cysteine arrangement (CC-C-C). These toxins are known to interact with adrenergic
and nicotinic acetylcholine receptors. Tsu1.1 itself has been shown to activate the appetite of
Drosophila melanogaster8. The structure was calculated using XPOLR-NIH with NOE peaks and
dihedral angles as restraints after resonance assignments were made. This initial structure
calculation was programmed to calculate 20 structures, for which the backbone RMSD was
~2.5 Å. Based on this structure calculation and the NOE data, we concluded that the disulfide
bond arrangement is Cys6-Cys12 and Cys7-Cys18. The structure calculation was then
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performed again using disulfide bond restraints, which keep a distance of ~2 Å between
cysteine sulfur atoms and the hydrogen atoms of these cysteines are removed. Lastly, we have
performed a refinement of the disulfide bonded Tsu1.1 structure using the EEFX simulation in
XPOLR-NIH in which the structure is calculated with implicit solvation. The 10 lowest energy
structures of the EEFX simulation have an RMSD of ~1.2 Å. We hope this structure will have
use in the field of rational drug design of potential ligands with targets such as adrenergic of
acetylcholine receptors involved with some disease pathology. The framework I family of
conotoxins, of which Tsu1.1 is a member, are known to target these types of receptors.
However, the direct targets of Tsu1.1 remain unknown. Discovery of such targets would be a
critical next step in the rational design of ligands with the same targets as Tsu1.1.
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